Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SMAD binding	ACVR1 USP9Y CREBBP ZFYVE9 RNF111	1.91e-04	86	123	5	GO:0046332
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	SIN3B ANK1 AMBRA1 ZFPM1 WNK1 CREBBP TFAP2A ZXDA STAT3 ZXDB LPIN1 RCOR1 KMT2D NKX2-1 TNRC6A CAPRIN1 CUX1 RBFOX2	2.64e-04	1160	123	18	GO:0030674
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	CREBBP LPIN1 ASXL2	2.80e-04	21	123	3	GO:0042975
GeneOntologyMolecularFunction	molecular adaptor activity	UBL7 SIN3B ANK1 AMBRA1 ZFPM1 WNK1 CREBBP TFAP2A ZXDA STAT3 ZXDB LPIN1 RCOR1 KMT2D NKX2-1 TNRC6A CAPRIN1 CUX1 RBFOX2	6.26e-04	1356	123	19	GO:0060090
GeneOntologyMolecularFunction	chromatin binding	SIN3B TSHZ3 FANCM CREBBP TFAP2A STAT3 WAC RCOR1 KMT2A CHD6 ASXL2 KDM6A CUX1	6.40e-04	739	123	13	GO:0003682
GeneOntologyMolecularFunction	transcription coregulator activity	SIN3B ZFPM1 CREBBP TFAP2A ZXDA ZXDB LPIN1 RCOR1 KMT2D NKX2-1 RBFOX2	7.15e-04	562	123	11	GO:0003712
HumanPheno	Prominent digit pad	FOXP2 CREBBP WAC KMT2D KMT2A KDM6A CAPRIN1	2.67e-07	48	49	7	HP:0011298
HumanPheno	Pilomatrixoma	CREBBP DICER1 KMT2D KDM6A	9.19e-07	9	49	4	HP:0030434
HumanPheno	Abnormal nasal tip morphology	CDK19 CUL7 RFX7 TFAP2A WAC COL18A1 KMT2D TBCK KMT2A ASXL2 KDM6A CAPRIN1 SIX2 SLX4 CUX1	1.72e-06	386	49	15	HP:0000436
HumanPheno	Clinodactyly	SIN3B NEDD4L FOXP2 ACVR1 REV3L CUL7 RFX7 FANCM CREBBP TFAP2A KMT2D TBCK ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	2.64e-06	574	49	18	HP:0030084
HumanPheno	Prominent fingertip pads	FOXP2 CREBBP WAC KMT2D KDM6A CAPRIN1	4.05e-06	46	49	6	HP:0001212
HumanPheno	Epicanthus	ANK1 FOXP2 POLRMT REV3L RFX7 FANCM CREBBP WAC COL18A1 KMT2D CCDC88A TBCK ASPM KMT2A ASXL2 KDM6A SIX2 SLX4	6.98e-06	614	49	18	HP:0000286
HumanPheno	Finger clinodactyly	NEDD4L FOXP2 ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	1.22e-05	452	49	15	HP:0040019
HumanPheno	Abnormality of globe location or size	POMT2 ANK1 NEDD4L FOXP2 CDK19 POLRMT FANCM CREBBP TFAP2A DICER1 STAT3 WAC KMT2D TBCK CNTNAP2 ASPM ADAMTS15 KMT2A NHS CHD6 ASXL2 KDM6A CAPRIN1 SIX2 SLX4 CUX1	1.43e-05	1246	49	26	HP:0000489
HumanPheno	Eversion of lateral third of lower eyelids	KMT2D KMT2A KDM6A	1.64e-05	6	49	3	HP:0007655
HumanPheno	Skin appendage neoplasm	CREBBP DICER1 KMT2D KDM6A	2.09e-05	18	49	4	HP:0012842
HumanPheno	Regional abnormality of skin	FOXP2 CDK19 CAST POLRMT WNK1 CREBBP TFAP2A STAT3 WAC TGM1 KMT2D ADAMTS15 KMT2A ASXL2 KDM6A CAPRIN1	2.48e-05	541	49	16	HP:0011356
HumanPheno	Clinodactyly of the 5th finger	NEDD4L ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	2.48e-05	420	49	14	HP:0004209
HumanPheno	Clinodactyly of hands	NEDD4L ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	2.55e-05	421	49	14	HP:0001157
HumanPheno	Deviation of the 5th finger	NEDD4L ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	2.55e-05	421	49	14	HP:0009179
HumanPheno	Telecanthus	FOXP2 RFX7 CREBBP TFAP2A COL18A1 KMT2D KMT2A CHD6 KDM6A	3.11e-05	173	49	9	HP:0000506
HumanPheno	Cafe-au-lait spot	REV3L RFX7 FANCM CREBBP KMT2D KDM6A CAPRIN1 SLX4	3.97e-05	137	49	8	HP:0000957
HumanPheno	Patent ductus arteriosus	ANK1 NEDD4L FOXP2 FANCM CREBBP WAC COL18A1 KMT2D KMT2A ASXL2 KDM6A SLX4 CUX1	4.21e-05	382	49	13	HP:0001643
HumanPheno	Abnormal external nose morphology	NEDD4L FOXP2 CDK19 POLRMT CUL7 RFX7 CREBBP TFAP2A DICER1 WAC COL18A1 KMT2D TBCK KMT2A CHD6 ASXL2 KDM6A CAPRIN1 SIX2 SLX4 CUX1	4.25e-05	916	49	21	HP:0010938
HumanPheno	Radial deviation of finger	NEDD4L ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	5.13e-05	448	49	14	HP:0009466
HumanPheno	Long palpebral fissure	RFX7 WAC KMT2D KMT2A KDM6A CUX1	5.16e-05	71	49	6	HP:0000637
HumanPheno	Radial deviation of the hand or of fingers of the hand	NEDD4L ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	6.24e-05	456	49	14	HP:0009485
HumanPheno	Branchial anomaly	ANK1 TFAP2A DICER1 WAC KMT2D KDM6A	8.79e-05	78	49	6	HP:0009794
HumanPheno	Abnormal size of the palpebral fissures	ANK1 FOXP2 RFX7 FANCM CREBBP WAC KMT2D KMT2A KDM6A SLX4 CUX1	8.99e-05	298	49	11	HP:0200007
HumanPheno	Abnormality of globe location	ANK1 NEDD4L FOXP2 CDK19 POLRMT FANCM CREBBP TFAP2A DICER1 STAT3 WAC KMT2D TBCK CNTNAP2 ASPM ADAMTS15 KMT2A ASXL2 KDM6A CAPRIN1 SIX2 SLX4 CUX1	9.14e-05	1122	49	23	HP:0100886
HumanPheno	Deviation of finger	NEDD4L FOXP2 ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	9.46e-05	537	49	15	HP:0004097
HumanPheno	Abnormal cornea morphology	POMT2 ANK1 REV3L FANCM TEK WNK1 CREBBP TFAP2A WAC TGM1 COL18A1 KMT2D TBCK NHS RP1 KDM6A CAPRIN1 SLX4	9.93e-05	744	49	18	HP:0000481
HumanPheno	Bulbous nose	CDK19 CUL7 WAC COL18A1 KMT2D TBCK KMT2A SLX4 CUX1	1.01e-04	201	49	9	HP:0000414
HumanPheno	Broad nasal tip	RFX7 TFAP2A WAC KMT2A ASXL2 KDM6A CAPRIN1 SIX2	1.15e-04	159	49	8	HP:0000455
HumanPheno	Overfolded helix	FOXP2 CREBBP TFAP2A KMT2D ASXL2 KDM6A	1.16e-04	82	49	6	HP:0000396
HumanPheno	Hypertelorism	ANK1 NEDD4L FOXP2 CDK19 FANCM CREBBP TFAP2A DICER1 STAT3 WAC KMT2D CNTNAP2 ADAMTS15 KMT2A ASXL2 KDM6A CAPRIN1 SIX2 SLX4	1.24e-04	830	49	19	HP:0000316
HumanPheno	Anteverted nares	NEDD4L POLRMT CUL7 RFX7 CREBBP TFAP2A DICER1 WAC KMT2D TBCK KMT2A ASXL2 KDM6A CAPRIN1 SIX2	1.50e-04	559	49	15	HP:0000463
HumanPheno	Upturned nose	NEDD4L POLRMT CUL7 RFX7 CREBBP TFAP2A DICER1 WAC KMT2D TBCK KMT2A ASXL2 KDM6A CAPRIN1 SIX2	1.50e-04	559	49	15	HP:0000427
HumanPheno	Short columella	CREBBP KMT2D KMT2A KDM6A	1.50e-04	29	49	4	HP:0002000
HumanPheno	Deviation of the hand or of fingers of the hand	NEDD4L FOXP2 ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	1.66e-04	564	49	15	HP:0009484
HumanPheno	Neoplasm of the middle ear	KMT2D NKX2-1 KDM6A	1.73e-04	12	49	3	HP:0100799
HumanPheno	Cholesteatoma	KMT2D NKX2-1 KDM6A	1.73e-04	12	49	3	HP:0009797
HumanPheno	Abnormal morphology of the nasal alae	NEDD4L POLRMT CUL7 RFX7 CREBBP TFAP2A DICER1 WAC KMT2D TBCK KMT2A CHD6 ASXL2 KDM6A CAPRIN1 SIX2	1.90e-04	639	49	16	HP:0000429
HumanPheno	Abnormally folded helix	FOXP2 CREBBP TFAP2A KMT2D ASXL2 KDM6A	1.95e-04	90	49	6	HP:0008544
HumanPheno	Abnormal 5th finger morphology	NEDD4L ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A KMT2D ADAMTS15 KMT2A CHD6 KDM6A CAPRIN1 SLX4	2.06e-04	509	49	14	HP:0004207
HumanPheno	Abnormal nostril morphology	NEDD4L POLRMT CUL7 RFX7 CREBBP TFAP2A DICER1 WAC KMT2D TBCK KMT2A ASXL2 KDM6A CAPRIN1 SIX2	2.06e-04	575	49	15	HP:0005288
HumanPheno	Lip pit	TFAP2A KMT2D KDM6A	2.24e-04	13	49	3	HP:0100267
HumanPheno	High palate	ANK1 FOXP2 CDK19 POLRMT REV3L RFX7 FANCM CREBBP TFAP2A STAT3 KMT2D TBCK ASPM ADAMTS15 KMT2A CHD6 KDM6A SLX4	2.33e-04	794	49	18	HP:0000218
HumanPheno	Preauricular pit	ANK1 TFAP2A DICER1 KMT2D KDM6A	2.65e-04	61	49	5	HP:0004467
HumanPheno	Abnormal alveolar type II pneumocyte morphology	KMT2D KDM6A	2.70e-04	3	49	2	HP:0033245
HumanPheno	Decreased proportion of CD4-positive, alpha-beta memory T cells	KMT2D KDM6A	2.70e-04	3	49	2	HP:0410386
HumanPheno	Type II pneumocyte hyperplasia	KMT2D KDM6A	2.70e-04	3	49	2	HP:0033328
HumanPheno	Abnormality of the forehead	POMT2 CDK19 CUL7 RFX7 FANCM CREBBP TFAP2A DICER1 STAT3 WAC COL18A1 KMT2D CCDC88A TBCK ASPM KMT2A CHD6 ASXL2 KDM6A CAPRIN1 SIX2 SLX4 CUX1	2.99e-04	1208	49	23	HP:0000290
HumanPheno	Reduced circulating growth hormone concentration	CREBBP KMT2D KDM6A	3.51e-04	15	49	3	HP:0034323
HumanPheno	Abnormal preputium morphology	FANCM KMT2D KDM6A SLX4	3.55e-04	36	49	4	HP:0100587
HumanPheno	Nasolacrimal duct obstruction	CREBBP TFAP2A KMT2D KDM6A	3.55e-04	36	49	4	HP:0000579
HumanPheno	Localized skin lesion	ANK1 NEDD4L ACVR1 REV3L RFX7 FANCM TEK WNK1 CREBBP TFAP2A DICER1 STAT3 KMT2D KMT2A CHD6 ASXL2 KDM6A CAPRIN1 SLX4	3.56e-04	897	49	19	HP:0011355
HumanPheno	Aplasia/hypoplasia involving bones of the hand	ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A WAC KMT2D KMT2A NHS CHD6 ASXL2 KDM6A SLX4	3.69e-04	538	49	14	HP:0005927
HumanPheno	Periauricular skin pits	ANK1 TFAP2A DICER1 KMT2D KDM6A	4.13e-04	67	49	5	HP:0100277
HumanPheno	Natal tooth	CREBBP KMT2D CHD6 KDM6A	4.39e-04	38	49	4	HP:0000695
HumanPheno	Pelvic kidney	WAC KMT2D KDM6A SLX4	4.39e-04	38	49	4	HP:0000125
HumanPheno	Abnormal number of teeth	CDK19 REV3L CREBBP TFAP2A KMT2D NKX2-1 ADAMTS15 KMT2A NHS CHD6 KDM6A CUX1	4.75e-04	421	49	12	HP:0006483
HumanPheno	Premature thelarche	CREBBP KMT2D KDM6A	5.17e-04	17	49	3	HP:0010314
HumanPheno	Abnormal calvaria morphology	NEDD4L FOXP2 CDK19 CUL7 RFX7 FANCM WNK1 CREBBP TFAP2A DICER1 STAT3 WAC COL18A1 KMT2D NKX2-1 TBCK ASPM KMT2A CHD6 KDM6A SIX2 SLX4 CUX1	5.34e-04	1254	49	23	HP:0002683
HumanPheno	Lower lip pit	TFAP2A KDM6A	5.37e-04	4	49	2	HP:0000196
HumanPheno	Paramedian lip pit	TFAP2A KDM6A	5.37e-04	4	49	2	HP:0100269
HumanPheno	Scimitar anomaly	KMT2D KDM6A	5.37e-04	4	49	2	HP:0011626
HumanPheno	Aplasia/hypoplasia affecting bones of the axial skeleton	POMT2 ANK1 NEDD4L FOXP2 ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A DICER1 KMT2D TBCK ASPM KMT2A CHD6 KDM6A CAPRIN1 SIX2 SLX4	5.59e-04	1008	49	20	HP:0009122
HumanPheno	Hypermelanotic macule	REV3L RFX7 FANCM CREBBP KMT2D KDM6A CAPRIN1 SLX4	5.72e-04	201	49	8	HP:0001034
HumanPheno	Abnormality of the jaws	POMT2 ANK1 NEDD4L FOXP2 REV3L CUL7 RFX7 FANCM CREBBP TFAP2A DICER1 KMT2D CCDC88A TBCK ASPM KMT2A NHS CHD6 ASXL2 KDM6A CAPRIN1 SLX4	5.75e-04	1175	49	22	HP:0000209
HumanPheno	Sacral dimple	ANK1 DICER1 KMT2D KMT2A KDM6A CAPRIN1	5.81e-04	110	49	6	HP:0000960
HumanPheno	Abnormal jaw morphology	POMT2 ANK1 NEDD4L FOXP2 REV3L CUL7 RFX7 FANCM CREBBP TFAP2A DICER1 KMT2D CCDC88A TBCK ASPM KMT2A NHS CHD6 ASXL2 KDM6A CAPRIN1 SLX4	5.83e-04	1176	49	22	HP:0030791
HumanPheno	Abnormal fingertip morphology	FOXP2 FANCM CREBBP WAC KMT2D KDM6A CAPRIN1 SLX4	6.11e-04	203	49	8	HP:0001211
HumanPheno	Dimple chin	TFAP2A KMT2D KDM6A	6.17e-04	18	49	3	HP:0010751
HumanPheno	Aplasia/hypoplasia involving bones of the upper limbs	ACVR1 REV3L CUL7 FANCM CREBBP TFAP2A WAC KMT2D KMT2A NHS CHD6 ASXL2 KDM6A SLX4	6.92e-04	572	49	14	HP:0006496
HumanPheno	Sacrococcygeal pilonidal abnormality	ANK1 DICER1 KMT2D KMT2A KDM6A CAPRIN1	7.03e-04	114	49	6	HP:0010767
HumanPheno	Abnormal nasal septum morphology	CREBBP TFAP2A KMT2D KMT2A KDM6A CAPRIN1	7.36e-04	115	49	6	HP:0000419
HumanPheno	Abnormal mandible morphology	POMT2 ANK1 NEDD4L REV3L CUL7 RFX7 FANCM CREBBP TFAP2A DICER1 KMT2D CCDC88A TBCK ASPM KMT2A NHS CHD6 ASXL2 KDM6A CAPRIN1 SLX4	8.04e-04	1118	49	21	HP:0000277
HumanPheno	Abnormal helix morphology	FOXP2 CREBBP TFAP2A WAC TGM1 KMT2D ASXL2 KDM6A	8.14e-04	212	49	8	HP:0011039
HumanPheno	Stage 3 chronic kidney disease	POLRMT NUP160	8.90e-04	5	49	2	HP:0012625
HumanPheno	Absent pubertal growth spurt	KMT2D KDM6A	8.90e-04	5	49	2	HP:0031087
HumanPheno	Supernumerary cusp	CREBBP NHS	8.90e-04	5	49	2	HP:0033777
HumanPheno	Branchial sinus	KMT2D KDM6A	8.90e-04	5	49	2	HP:0100272
HumanPheno	Advanced eruption of teeth	CREBBP KMT2D CHD6 KDM6A	9.17e-04	46	49	4	HP:0006288
HumanPheno	Skin dimple	ANK1 DICER1 KMT2D KMT2A KDM6A CAPRIN1	9.21e-04	120	49	6	HP:0010781
HumanPheno	Abnormality of calvarial morphology	NEDD4L FOXP2 CDK19 CUL7 RFX7 FANCM CREBBP TFAP2A DICER1 STAT3 WAC COL18A1 KMT2D TBCK ASPM KMT2A CHD6 KDM6A SIX2 SLX4 CUX1	9.79e-04	1134	49	21	HP:0002648
HumanPheno	Frontal bossing	CDK19 CUL7 RFX7 FANCM CREBBP DICER1 STAT3 WAC KMT2D TBCK KMT2A CHD6 KDM6A SIX2 SLX4 CUX1	9.93e-04	738	49	16	HP:0002007
HumanPheno	Short palpebral fissure	FOXP2 FANCM CREBBP WAC KMT2A SLX4	1.00e-03	122	49	6	HP:0012745
HumanPheno	Abnormal facial shape	SIN3B NEDD4L FOXP2 CUL7 RFX7 FANCM CREBBP TFAP2A STAT3 WAC COL18A1 KMT2D NKX2-1 TBCK CNTNAP2 KMT2A NHS CHD6 ASXL2 CAPRIN1 SLX4 CUX1	1.01e-03	1221	49	22	HP:0001999
HumanPheno	Dolichocephaly	NEDD4L CUL7 RFX7 FANCM TFAP2A KMT2D KMT2A SLX4	1.01e-03	219	49	8	HP:0000268
HumanPheno	Abnormal shape of the frontal region	CDK19 CUL7 RFX7 FANCM CREBBP DICER1 STAT3 WAC KMT2D TBCK KMT2A CHD6 KDM6A SIX2 SLX4 CUX1	1.04e-03	741	49	16	HP:0011218
HumanPheno	Choanal atresia	FANCM WAC KMT2D CHD6 KDM6A SLX4	1.05e-03	123	49	6	HP:0000453
HumanPheno	Abnormal frontal bone morphology	CDK19 CUL7 RFX7 FANCM CREBBP DICER1 STAT3 WAC KMT2D TBCK KMT2A CHD6 KDM6A SIX2 SLX4 CUX1	1.05e-03	742	49	16	HP:0430000
HumanPheno	Abnormality of corneal size	POMT2 ANK1 FANCM TEK TFAP2A WAC KMT2D NHS RP1 KDM6A CAPRIN1 SLX4	1.08e-03	461	49	12	HP:0001120
HumanPheno	Congenital malformation of the great arteries	ANK1 NEDD4L FOXP2 FANCM CREBBP WAC COL18A1 KMT2D KMT2A ASXL2 KDM6A SLX4 CUX1	1.09e-03	529	49	13	HP:0011603
HumanPheno	Diagnostic behavioral phenotype	SIN3B FOXP2 CDK19 REV3L RFX7 CREBBP DICER1 WAC KMT2D NKX2-1 TBCK CNTNAP2 KMT2A NHS KDM6A CAPRIN1	1.14e-03	747	49	16	HP:0025783
HumanPheno	Abnormality of upper lip vermillion	CDK19 RFX7 CREBBP WAC KMT2D TBCK ASPM KMT2A ASXL2 KDM6A CAPRIN1 CUX1	1.14e-03	464	49	12	HP:0011339
HumanPheno	Abnormal eyelid morphology	ANK1 FOXP2 CDK19 POLRMT REV3L RFX7 FANCM CREBBP TFAP2A WAC TGM1 COL18A1 KMT2D CCDC88A TBCK CNTNAP2 ASPM KMT2A CHD6 ASXL2 KDM6A SIX2 SLX4 CUX1	1.15e-03	1408	49	24	HP:0000492
HumanPheno	Skin pit	ANK1 TFAP2A DICER1 KMT2D KDM6A	1.17e-03	84	49	5	HP:0100276
HumanPheno	Thin upper lip vermilion	RFX7 CREBBP WAC KMT2D ASPM KMT2A ASXL2 KDM6A CAPRIN1 CUX1	1.18e-03	339	49	10	HP:0000219
HumanPheno	Thin lips	RFX7 CREBBP WAC KMT2D ASPM KMT2A ASXL2 KDM6A CAPRIN1 CUX1	1.18e-03	339	49	10	HP:0000213
HumanPheno	Autistic behavior	SIN3B FOXP2 CDK19 REV3L RFX7 CREBBP DICER1 WAC KMT2D TBCK CNTNAP2 KMT2A NHS KDM6A CAPRIN1	1.23e-03	678	49	15	HP:0000729
HumanPheno	Supernumerary tooth	CREBBP KMT2D NHS CHD6 KDM6A	1.23e-03	85	49	5	HP:0011069
HumanPheno	Abnormal lacrimal duct morphology	CREBBP TFAP2A KMT2D KDM6A	1.26e-03	50	49	4	HP:0011481
HumanPheno	Dilatation of renal calices	WAC KMT2A	1.33e-03	6	49	2	HP:0100581
HumanPheno	Abnormal renal calyx morphology	WAC KMT2A	1.33e-03	6	49	2	HP:0011130
MousePheno	perinatal lethality	SIN3B TSHZ3 ANK1 NEDD4L FOXP2 MATR3 UBR4 ZFPM1 ACVR1 CUL7 F5 CREBBP TFAP2A DICER1 STAT3 TGM1 TTBK2 LATS1 NKX2-1 ZNF516 KMT2A KDM6A CAPRIN1 MEX3B SIX2 SLX4 CUX1	1.43e-08	1130	100	27	MP:0002081
MousePheno	lethality during fetal growth through weaning, complete penetrance	SIN3B TSHZ3 ANK1 NEDD4L FOXP2 MATR3 UBR4 AMBRA1 ACVR1 CUL7 F5 CREBBP TFAP2A DICER1 STAT3 TGM1 TTBK2 RCOR1 MTF1 NKX2-1 ZNF516 SEC24B KMT2A ADGRL2 KDM6A CAPRIN1 SIX2 CNOT4	4.00e-08	1269	100	28	MP:0011111
MousePheno	perinatal lethality, complete penetrance	SIN3B TSHZ3 MATR3 UBR4 ACVR1 CUL7 F5 TFAP2A STAT3 TGM1 TTBK2 NKX2-1 ZNF516 KMT2A KDM6A CAPRIN1 SIX2	1.08e-05	712	100	17	MP:0011089
MousePheno	embryonic lethality during organogenesis	POMT2 UBR4 DDX42 AMBRA1 ZFPM1 ACVR1 REV3L TEK WNK1 F5 CREBBP DICER1 TTBK2 KMT2D TNRC6A KMT2A BICRAL KDM6A RNF111	1.21e-05	876	100	19	MP:0006207
MousePheno	embryonic lethality during organogenesis, complete penetrance	POMT2 UBR4 DDX42 ZFPM1 ACVR1 REV3L TEK WNK1 CREBBP TTBK2 KMT2D TNRC6A KMT2A BICRAL KDM6A RNF111	3.46e-05	700	100	16	MP:0011098
MousePheno	embryonic lethality, incomplete penetrance	FOXP2 TRO MATR3 AMBRA1 ZFPM1 F5 CREBBP DICER1 RCOR1 TNRC6A KDM6A SLX4	3.52e-05	410	100	12	MP:0011102
MousePheno	prenatal lethality prior to heart atrial septation, incomplete penetrance	FOXP2 TRO MATR3 AMBRA1 ZFPM1 F5 CREBBP DICER1 RCOR1 TNRC6A KDM6A SLX4	3.52e-05	410	100	12	MP:0031660
MousePheno	neonatal lethality	SIN3B TSHZ3 ANK1 NEDD4L MATR3 UBR4 ACVR1 CUL7 F5 TGM1 LATS1 NKX2-1 ZNF516 CAPRIN1 MEX3B SIX2 CUX1	4.73e-05	799	100	17	MP:0002058
MousePheno	abnormal visceral yolk sac morphology	UBR4 ZFPM1 REV3L WNK1 F5 CREBBP SEC24B TNRC6A KDM6A	4.79e-05	236	100	9	MP:0001718
MousePheno	perinatal lethality, incomplete penetrance	ANK1 NEDD4L FOXP2 ZFPM1 F5 CREBBP DICER1 LATS1 KMT2A KDM6A MEX3B SLX4 CUX1	5.90e-05	503	100	13	MP:0011090
MousePheno	prenatal lethality, incomplete penetrance	ANK1 FOXP2 TRO MATR3 AMBRA1 ZFPM1 F5 CREBBP DICER1 TTBK2 RCOR1 LATS1 TNRC6A ASXL2 KDM6A SLX4	7.52e-05	747	100	16	MP:0011101
MousePheno	abnormal cardiovascular development	MATR3 UBR4 ZFPM1 REV3L CUL7 TEK WNK1 CREBBP TFAP2A DICER1 ADCY9 TTBK2 CCDC88A SEC24B ADGRL2 KDM6A	1.72e-04	802	100	16	MP:0002925
MousePheno	sacral vertebral transformation	HOXC8 KMT2A ASXL2	1.86e-04	16	100	3	MP:0004617
MousePheno	abnormal extraembryonic tissue morphology	POMT2 UBR4 DDX42 ZFPM1 ACVR1 REV3L CUL7 TEK WNK1 F5 CREBBP DICER1 ADCY9 SEC24B TNRC6A KDM6A CNOT4	2.25e-04	908	100	17	MP:0002086
MousePheno	lethality throughout fetal growth and development	AMBRA1 ZFPM1 CUL7 CREBBP DICER1 MTF1 SEC24B KMT2A ADGRL2 SLX4 CNOT4	2.74e-04	435	100	11	MP:0006208
MousePheno	increased erythroid progenitor cell number	SIN3B ANK1 ZFPM1 KMT2A	2.93e-04	45	100	4	MP:0003135
MousePheno	decreased common myeloid progenitor cell number	ANK1 CREBBP KMT2A SLX4	3.47e-04	47	100	4	MP:0008813
Domain	UBA-like	UBL7 ILRUN UBQLN1 LATS1 TNRC6A	6.38e-05	64	123	5	IPR009060
Domain	Teashirt_fam	TSHZ3 TSHZ2	1.29e-04	3	123	2	IPR027008
Domain	FYrich_C	KMT2D KMT2A	4.25e-04	5	123	2	IPR003889
Domain	FYrich_N	KMT2D KMT2A	4.25e-04	5	123	2	IPR003888
Domain	FYRC	KMT2D KMT2A	4.25e-04	5	123	2	SM00542
Domain	FYRN	KMT2D KMT2A	4.25e-04	5	123	2	SM00541
Domain	FYRN	KMT2D KMT2A	4.25e-04	5	123	2	PF05964
Domain	FYRC	KMT2D KMT2A	4.25e-04	5	123	2	PF05965
Domain	FYRC	KMT2D KMT2A	4.25e-04	5	123	2	PS51543
Domain	FYRN	KMT2D KMT2A	4.25e-04	5	123	2	PS51542
Pubmed	Human transcription factor protein interaction networks.	ZHX3 SIN3B TSHZ3 FOXP2 ATXN7L1 MATR3 UBR4 REL CUL7 MAP7 RFX7 CREBBP STAT3 RCOR1 KMT2D RBM27 ZNF516 SEC24B SEC16A TNRC6A KMT2A CHD6 ASXL2 KDM6A CAPRIN1 SLX4 CUX1 PYGO1	1.62e-13	1429	125	28	35140242
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NEDD4L MATR3 HJURP KCTD8 MAP7 RFX7 WNK1 ANKRD27 STAT3 CCDC88A LATS1 SEC24B SEC16A KMT2A NHS AKAP11 SIPA1L2 MEX3B CNOT4 KLC1	3.74e-11	861	125	20	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SIN3B TSHZ3 UBR4 POLRMT RCOR1 KMT2D CCDC88A FAM193A ZNF516 SEC16A TNRC6A CHD6 CUX1 KLC1	3.86e-10	418	125	14	34709266
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SIN3B MATR3 CAST CREBBP TFAP2A STAT3 KMT2D LATS1 RBM27 SEC24B SEC16A KMT2A KDM6A CUX1 KLC1	1.44e-09	549	125	15	38280479
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	FOXP2 VEZT ATXN7L1 BAG4 POLRMT AMBRA1 REV3L CUL7 MAP7 CREBBP DICER1 ADCY9 RCOR1 SEC16A TNRC6A ASPM CRNN BICRAL SIPA1L2 ADGRL2	3.33e-09	1116	125	20	31753913
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ZHX3 SIN3B DDX42 CREBBP WAC RCOR1 KMT2D RBM27 KMT2A KDM6A CUX1	3.96e-09	268	125	11	33640491
Pubmed	A census of human transcription factors: function, expression and evolution.	ZHX3 TSHZ3 FOXP2 TSHZ2 REL ZFPM1 RFX8 RFX7 ZNF236 TFAP2A STAT3 RCOR1 KMT2D HOXC8 MTF1 NKX2-1 KMT2A SIX2	4.70e-09	908	125	18	19274049
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP7 DICER1 CCDC88A FAM193A SEC16A TNRC6A NHS AKAP11 SIPA1L2 CAPRIN1	4.81e-09	209	125	10	36779422
Pubmed	Interaction network of human early embryonic transcription factors.	TSHZ3 FOXP2 RFX7 CREBBP RCOR1 KMT2D ZNF516 SEC16A KMT2A ASXL2 KDM6A SLX4	5.88e-09	351	125	12	38297188
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MATR3 AMBRA1 DICER1 KIAA1614 ANKRD27 ADCY9 CCDC88A RBM27 ZNF516 CNTNAP2 TNRC6A PCNX1 AKAP11 ADGRL2	7.84e-09	529	125	14	14621295
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SIN3B FOXP2 TRO UBR4 POLRMT REL REV3L CUL7 CREBBP TFAP2A STAT3 TGM1 KMT2D ASXL2 ADGRL2 NUP160 CUX1	1.30e-08	857	125	17	25609649
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SIN3B MATR3 FAM171B CCDC88A FAM193A SEC24B SEC16A TNRC6A NHS SIPA1L2	4.26e-08	263	125	10	34702444
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZHX3 SIN3B FOXP2 CREBBP TFAP2A STAT3 HOXC8 MTF1 NKX2-1 KMT2A KLF17 SIX2 CUX1 RNF111 PYGO1	4.30e-08	709	125	15	22988430
Pubmed	Leveraging the Mendelian disorders of the epigenetic machinery to systematically map functional epigenetic variation.	CREBBP KMT2D KDM6A	4.53e-08	3	125	3	34463256
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZHX3 UBR4 MC3R ELOVL5 MUC16 REV3L CREBBP TFAP2A TTBK2 KMT2D ZNF516 CHD6 KDM6A CUX1	8.02e-08	638	125	14	31182584
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ZHX3 CDK19 WNK1 DICER1 ADCY9 SEC16A PCNX1 AKAP11 CHD6	1.35e-07	225	125	9	12168954
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SIN3B MATR3 DDX42 MAP7 RFX7 FANCM TFAP2A WAC RCOR1 KMT2D RBM27 KMT2A CHD6 ASXL2 ZCCHC7 KDM6A SIX2 CUX1 RBFOX2	1.95e-07	1294	125	19	30804502
Pubmed	A human MAP kinase interactome.	NEDD4L WNK1 CREBBP CCDC88A LATS1 TNRC6A BICRAL CHD6 CUX1 RBFOX2 RNF111 PYGO1	2.05e-07	486	125	12	20936779
Pubmed	Functional proteomics mapping of a human signaling pathway.	UBQLN1 NEDD4L UBR4 CREBBP ANKRD27 KMT2D ZFYVE9 SLC12A4 CHD6 ASXL2 ZCCHC7 KDM6A RNF111	2.33e-07	591	125	13	15231748
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZHX3 SIN3B MATR3 DDX42 CAST WNK1 STAT3 WAC FAM193A RBM27 SEC24B SEC16A MASTL KMT2A SIPA1L2 KLC1	2.62e-07	934	125	16	33916271
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TSHZ3 UBQLN1 NEDD4L TRO UBR4 HJURP WNK1 LATS1 FAM193A MEX3B KLC1	4.77e-07	430	125	11	35044719
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	MATR3 BAG4 POLRMT MAP7 RBM27 SEC24B SEC16A TNRC6A CAPRIN1	7.07e-07	274	125	9	34244482
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SIN3B TSHZ3 UBR4 CUL7 SEC16A SGO2 AKAP11 CHD6 CUX1	8.97e-07	282	125	9	23667531
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	VEZT CUL7 FAM171B TFAP2A ADCY9 KMT2D CCDC88A ZFYVE9 SLC12A4 SEC24B SEC16A TNRC6A NHS ADGRL2 KDM6A SIX2	1.20e-06	1049	125	16	27880917
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZHX3 SIN3B UBQLN1 CREBBP TFAP2A WAC RCOR1 KMT2D RBM27 ZNF516 KMT2A BICRAL ASXL2 KDM6A CAPRIN1 CUX1	2.30e-06	1103	125	16	34189442
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	KMT2D KMT2A KDM6A	2.50e-06	8	125	3	22722839
Pubmed	WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.	KMT2D HOXC8 KMT2A	3.75e-06	9	125	3	15960974
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	MATR3 RFX7 TFAP2A RBM27 SEC16A TNRC6A NUP160	4.22e-06	180	125	7	35198878
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	SIN3B DDX42 MAP7 STAT3 CCDC88A RBM27 SEC16A ASPM	4.33e-06	256	125	8	33397691
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SBSN KMT2D FAM193A RBM27 SEC24B SEC16A TNRC6A	4.88e-06	184	125	7	32908313
Pubmed	Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.	FOXP2 CNTNAP2 CUX1	5.34e-06	10	125	3	21962519
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	VEZT UBR4 BAG4 DDX42 POLRMT MAP7 DICER1 ADCY9 COL18A1 CCDC88A FAM193A ASPM AKAP11 SIPA1L2 ADGRL2 CAPRIN1 CUX1 KLC1	6.41e-06	1487	125	18	33957083
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	TSHZ2 WNK1 WAC FAM193A TBCK ASPM NHS SGO2 CHD6	7.03e-06	363	125	9	14691545
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZHX3 MATR3 DDX42 CAST FANCM TFAP2A WAC RBM27 SEC16A KMT2A SGO2 ZCCHC7 SLX4 CUX1	9.07e-06	954	125	14	36373674
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CUL7 MAP7 WNK1 CREBBP CCDC88A ZNF516 SEC16A TNRC6A ASPM SIPA1L2 SLX4	9.59e-06	588	125	11	38580884
Pubmed	Functional kinomics establishes a critical node of volume-sensitive cation-Cl- cotransporter regulation in the mammalian brain.	WNK1 SLC12A4 MASTL	9.74e-06	12	125	3	27782176
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PDE4A UBR4 POLRMT AMBRA1 ZFPM1 REV3L ZNF236 WNK1 ADCY9 KMT2D SLC12A4 ZNF516 SEC16A PCNX1 SIPA1L2	1.07e-05	1105	125	15	35748872
Pubmed	Multiple loci influencing hippocampal degeneration identified by genome scan.	F5 COL18A1 CHD6	1.26e-05	13	125	3	22745009
Pubmed	Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.	CEACAM5 MUC16	1.28e-05	2	125	2	24680660
Pubmed	Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.	KMT2D KDM6A	1.28e-05	2	125	2	24739679
Pubmed	Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.	KMT2D KDM6A	1.28e-05	2	125	2	31935506
Pubmed	Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.	LATS1 CUX1	1.28e-05	2	125	2	19656388
Pubmed	Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.	CREBBP KMT2A	1.28e-05	2	125	2	12205094
Pubmed	Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.	KMT2D KDM6A	1.28e-05	2	125	2	32803813
Pubmed	Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.	CEACAM5 MUC16	1.28e-05	2	125	2	34801967
Pubmed	A study of the role of the FOXP2 and CNTNAP2 genes in persistent developmental stuttering.	FOXP2 CNTNAP2	1.28e-05	2	125	2	24807205
Pubmed	Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.	KMT2D KDM6A	1.28e-05	2	125	2	23184418
Pubmed	Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3.	STAT3 TGM1	1.28e-05	2	125	2	19049964
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2D KMT2A	1.28e-05	2	125	2	26711341
Pubmed	Contactin‑associated protein‑like 2 expression in SH‑SY5Y cells is upregulated by a FOXP2 mutant with a shortened poly‑glutamine tract.	FOXP2 CNTNAP2	1.28e-05	2	125	2	26497390
Pubmed	Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2.	FOXP2 CNTNAP2	1.28e-05	2	125	2	23277129
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2D KMT2A	1.28e-05	2	125	2	24423662
Pubmed	Identification of a novel human member of the DEAD box protein family.	DDX42 DICER1	1.28e-05	2	125	2	10727850
Pubmed	Kabuki syndrome: clinical and molecular diagnosis in the first year of life.	KMT2D KDM6A	1.28e-05	2	125	2	25281733
Pubmed	Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals.	KMT2D KDM6A	1.28e-05	2	125	2	29907798
Pubmed	Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia.	KMT2D KDM6A	1.28e-05	2	125	2	26049589
Pubmed	A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome.	CREBBP KMT2D	1.28e-05	2	125	2	27999180
Pubmed	Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome.	KMT2D KDM6A	1.28e-05	2	125	2	22840376
Pubmed	Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.	KMT2D KDM6A	1.28e-05	2	125	2	27302555
Pubmed	Kabuki Syndrome	KMT2D KDM6A	1.28e-05	2	125	2	21882399
Pubmed	Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.	KMT2D KDM6A	1.28e-05	2	125	2	30556359
Pubmed	A functional genetic link between distinct developmental language disorders.	FOXP2 CNTNAP2	1.28e-05	2	125	2	18987363
Pubmed	Paeoniflorin Regulates NEDD4L/STAT3 Pathway to Induce Ferroptosis in Human Glioma Cells.	NEDD4L STAT3	1.28e-05	2	125	2	36618071
Pubmed	MLL2 and KDM6A mutations in patients with Kabuki syndrome.	KMT2D KDM6A	1.28e-05	2	125	2	23913813
Pubmed	Duplicated zinc finger protein genes on the proximal short arm of the human X chromosome: isolation, characterization and X-inactivation studies.	ZXDA ZXDB	1.28e-05	2	125	2	8268913
Pubmed	MLL becomes functional through intra-molecular interaction not by proteolytic processing.	HOXC8 KMT2A	1.28e-05	2	125	2	24040009
Pubmed	Prenatal and perinatal history in Kabuki Syndrome.	KMT2D KDM6A	1.28e-05	2	125	2	31654559
Pubmed	The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.	KMT2D KDM6A	1.28e-05	2	125	2	31883305
Pubmed	Cntnap2 expression in the cerebellum of Foxp2(R552H) mice, with a mutation related to speech-language disorder.	FOXP2 CNTNAP2	1.28e-05	2	125	2	22133810
Pubmed	SETting up the genome: KMT2D and KDM6A genomic function in the Kabuki syndrome craniofacial developmental disorder.	KMT2D KDM6A	1.28e-05	2	125	2	37800171
Pubmed	Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.	PDE4A PDE4C	1.28e-05	2	125	2	23043089
Pubmed	Loss of signal transducer and activator of transcription 3 (STAT3) signaling during elevated activity causes vulnerability in hippocampal neurons.	STAT3 KCND2	1.28e-05	2	125	2	23115188
Pubmed	Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.	TSHZ3 TSHZ2	1.28e-05	2	125	2	21423795
Pubmed	Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.	KMT2D KDM6A	1.28e-05	2	125	2	25972376
Pubmed	Prenatal Phenotype of Kabuki Syndrome: Seven Case Series.	KMT2D KDM6A	1.28e-05	2	125	2	36436503
Pubmed	Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong.	KMT2D KDM6A	1.28e-05	2	125	2	33314698
Pubmed	Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain.	CREBBP KMT2A	1.28e-05	2	125	2	20969867
Pubmed	Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling.	AMBRA1 STAT3	1.28e-05	2	125	2	34302498
Pubmed	Ultrasonic vocalization in murine experimental stroke: A mechanistic model of aphasia.	FOXP2 CNTNAP2	1.28e-05	2	125	2	26889967
Pubmed	STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis.	STAT3 CCDC88A	1.28e-05	2	125	2	23066027
Pubmed	Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited.	KMT2D KDM6A	1.28e-05	2	125	2	26898171
Pubmed	Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.	STAT3 COL18A1	1.28e-05	2	125	2	23463096
Pubmed	Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.	CEACAM5 MUC16	1.28e-05	2	125	2	22941175
Pubmed	Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring.	KMT2D KDM6A	1.28e-05	2	125	2	26841933
Pubmed	Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas.	DICER1 KMT2D	1.28e-05	2	125	2	26841698
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	TFAP2A RCOR1 KMT2D KDM6A CUX1	1.28e-05	83	125	5	28794006
Pubmed	Gene expression in the developing mouse retina by EST sequencing and microarray analysis.	ILRUN RFX8 RFX7 ASPM NHS KLC1	1.31e-05	142	125	6	11812828
Pubmed	Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.	MATR3 UBR4 AMBRA1 TGM1 ASPM	1.36e-05	84	125	5	29563501
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZHX3 TSHZ3 CREBBP KMT2D ZNF516 SEC16A BICRAL KDM6A CUX1	1.46e-05	398	125	9	35016035
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UBR4 LPIN1 RCOR1 KCND2 BICRAL	1.62e-05	87	125	5	12465718
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	DDX42 AMBRA1 MAP7 CREBBP HOXC8 SEC16A TNRC6A ADGRL2	1.62e-05	307	125	8	37499664
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 NEDD4L TRO CDK19 UNC5A SEC16A CHD6 ASXL2 SIPA1L2	1.74e-05	407	125	9	12693553
Pubmed	Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.	KMT2D HOXC8 KMT2A	2.00e-05	15	125	3	14992727
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	UBL7 MATR3 BAG4 HJURP AMBRA1 LPIN1 SIPA1L2	2.20e-05	232	125	7	25515538
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MAP7 WNK1 F5 CREBBP RCOR1 RBM27 ZNF516 SEC16A KMT2A SGO2 CHD6	2.25e-05	645	125	11	25281560
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	NEDD4L FAM171B ADCY9 CCDC88A ZFYVE9 SEC16A NHS SIPA1L2 ADGRL2	2.27e-05	421	125	9	36976175
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SIN3B MATR3 UBR4 ZNF236 WNK1 DICER1 WAC FAM193A SLC12A4 MTF1 SEC16A ASPM KMT2A NHS CAPRIN1 PADI3	2.30e-05	1327	125	16	32694731
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ZHX3 PDE4C MATR3 CAST ZFPM1 RFX7 KMT2D LATS1 ZNF516 SEC16A KMT2A KDM6A	2.41e-05	774	125	12	15302935
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	CUL7 USP9Y CREBBP DICER1 SEC16A MASTL KMT2A AKAP11 RNF111	2.78e-05	432	125	9	23455922
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	POLRMT AMBRA1 DICER1 RBM27 SEC16A SGO2 CAPRIN1 NUP160 SLX4	3.21e-05	440	125	9	34244565
Interaction	TLE3 interactions	TSHZ3 CREBBP WAC KMT2D HOXC8 FAM193A TNRC6A MASTL KMT2A CHD6 ASXL2 SIX2 CNOT4 CUX1 KLC1	9.86e-09	376	123	15	int:TLE3
Interaction	TRIM66 interactions	VEZT AMBRA1 CUL7 MAP7 RCOR1 SEC16A TNRC6A ASPM CRNN SIPA1L2 ADGRL2	5.26e-08	205	123	11	int:TRIM66
Interaction	PHF21A interactions	SIN3B TSHZ3 UBR4 POLRMT RCOR1 KMT2D CCDC88A FAM193A ZNF516 SEC16A TNRC6A CHD6 KLC1	1.83e-07	343	123	13	int:PHF21A
Interaction	WWTR1 interactions	SIN3B CREBBP TFAP2A STAT3 KMT2D LATS1 RBM27 NKX2-1 SEC24B SEC16A KMT2A KDM6A CUX1 KLC1	3.05e-07	422	123	14	int:WWTR1
Interaction	RCOR1 interactions	SIN3B TSHZ3 MATR3 UBR4 POLRMT RCOR1 KMT2D CCDC88A FAM193A NKX2-1 ZNF516 SEC16A CHD6 CUX1 KLC1	3.47e-07	494	123	15	int:RCOR1
Interaction	GATA2 interactions	ZFPM1 CREBBP STAT3 RCOR1 KMT2D ZNF516 CHD6 ASXL2 KDM6A CUX1	4.01e-07	199	123	10	int:GATA2
Interaction	CTNNB1 interactions	NEDD4L VEZT MATR3 CREBBP TFAP2A KMT2D CCDC88A FAM193A ZFYVE9 SEC24B CNTNAP2 SEC16A ASPM KMT2A NHS CHD6 ASXL2 SIPA1L2 CAPRIN1 CUX1 PYGO1	7.58e-07	1009	123	21	int:CTNNB1
Interaction	STAT4 interactions	CREBBP STAT3 KMT2D SEC24B SEC16A	3.33e-06	38	123	5	int:STAT4
Interaction	CREBBP interactions	REL ACVR1 CREBBP STAT3 TGM1 KMT2D LATS1 MTF1 NKX2-1 KMT2A ZCCHC7 KDM6A SLX4 CUX1 RNF111	3.80e-06	599	123	15	int:CREBBP
Interaction	EMD interactions	ANK1 VEZT ELOVL5 POLRMT AMBRA1 REL CUL7 TEK ADCY9 RCOR1 LATS1 NKX2-1 SEC24B SEC16A TNRC6A ASXL2 NUP160	6.14e-06	789	123	17	int:EMD
Interaction	SOX5 interactions	ZHX3 TSHZ3 FOXP2 RCOR1 KMT2D CHD6 CAPRIN1 CUX1	6.90e-06	162	123	8	int:SOX5
Interaction	NR3C1 interactions	ZHX3 NEDD4L UBR4 MC3R ELOVL5 MUC16 REV3L CREBBP TFAP2A SBSN STAT3 TTBK2 RCOR1 KMT2D ZNF516 CHD6 KDM6A CUX1 RBFOX2	6.94e-06	974	123	19	int:NR3C1
Interaction	TNRC6A interactions	FANCM WNK1 LATS1 FAM193A SEC24B SEC16A TNRC6A MEX3B CNOT4 RBFOX2	8.61e-06	280	123	10	int:TNRC6A
Interaction	TNRC6B interactions	RCOR1 LATS1 FAM193A SEC24B CNTNAP2 SEC16A TNRC6A CAPRIN1 MEX3B CNOT4	9.17e-06	282	123	10	int:TNRC6B
Interaction	KLF3 interactions	ZHX3 TSHZ3 RFX7 RCOR1 KMT2D ZNF516 KMT2A CHD6 KDM6A	1.12e-05	228	123	9	int:KLF3
Interaction	RNF43 interactions	SIN3B MATR3 BAG4 FAM171B CCDC88A FAM193A SEC24B SEC16A TNRC6A NHS SIPA1L2 NUP160	1.21e-05	427	123	12	int:RNF43
Interaction	TLX1 interactions	CREBBP RCOR1 KMT2D ZNF516 ASXL2 KDM6A CUX1 PYGO1	1.21e-05	175	123	8	int:TLX1
Interaction	TEAD1 interactions	TSHZ3 CREBBP KMT2D NKX2-1 ZNF516 ASXL2 KDM6A CUX1	1.27e-05	176	123	8	int:TEAD1
Interaction	PBX1 interactions	SIN3B NEDD4L TSHZ2 UBR4 CREBBP HOXC8	1.35e-05	85	123	6	int:PBX1
Interaction	PAX6 interactions	TSHZ3 PDE4C CREBBP KMT2D HOXC8 ZNF516 CHD6 ASXL2 KDM6A CUX1 RNF111	1.53e-05	366	123	11	int:PAX6
Interaction	SP7 interactions	SIN3B TSHZ3 CREBBP RCOR1 KMT2D RBM27 ZNF516 KDM6A CUX1 PYGO1	1.76e-05	304	123	10	int:SP7
Interaction	SMG7 interactions	TSHZ3 CREBBP TGM1 KMT2D LATS1 FAM193A SEC16A TNRC6A CAPRIN1 MEX3B	2.65e-05	319	123	10	int:SMG7
Interaction	GSK3A interactions	MAP7 RFX7 DICER1 SBSN CCDC88A FAM193A SEC16A TNRC6A NHS AKAP11 SIPA1L2 SLX4	2.75e-05	464	123	12	int:GSK3A
Interaction	FBXO38 interactions	TSHZ3 ATXN7L1 CREBBP ZXDA ZXDB SGO2 CUX1	3.06e-05	145	123	7	int:FBXO38
Interaction	FEV interactions	FOXP2 CREBBP KMT2D KMT2A CHD6 ASXL2 KDM6A CUX1	3.53e-05	203	123	8	int:FEV
Interaction	EGLN3 interactions	UBR4 HJURP AMBRA1 REL CREBBP DICER1 LPIN1 CCDC88A FAM193A ZFYVE9 RBM27 SEC24B SEC16A ASPM MASTL SGO2 AKAP11 SIPA1L2 NUP160 SLX4 RBFOX2	3.59e-05	1296	123	21	int:EGLN3
Interaction	NUP155 interactions	VEZT ELOVL5 CUL7 ADCY9 KMT2D ZFYVE9 NKX2-1 SEC24B SEC16A TNRC6A NUP160 SLX4	3.60e-05	477	123	12	int:NUP155
Interaction	YWHAH interactions	NEDD4L MATR3 HJURP MAP7 RFX7 WNK1 CREBBP ANKRD27 CCDC88A LATS1 SEC24B SEC16A KMT2A NHS AKAP11 SIPA1L2 MEX3B CNOT4 KLC1	3.86e-05	1102	123	19	int:YWHAH
Interaction	RBBP4 interactions	SIN3B TSHZ3 HJURP ZFPM1 CUL7 CREBBP ANKRD27 RCOR1 NKX2-1 KMT2A ASXL2 CAPRIN1 CUX1	4.88e-05	573	123	13	int:RBBP4
Interaction	VSX1 interactions	TSHZ3 USP9Y NKX2-1 ZNF516 CHD6	5.18e-05	66	123	5	int:VSX1
Interaction	ANKHD1 interactions	BAG4 AMBRA1 RCOR1 SEC16A MEX3B SIX2 SLX4 RBFOX2	5.48e-05	216	123	8	int:ANKHD1
Interaction	OCLN interactions	UBQLN1 NEDD4L ELOVL5 FAM171B ADCY9 CCDC88A ZFYVE9 SEC24B NHS PCNX1 SIPA1L2 ADGRL2	5.66e-05	500	123	12	int:OCLN
Interaction	KDM1A interactions	SIN3B TSHZ3 UBR4 POLRMT ZFPM1 STAT3 RCOR1 KMT2D CCDC88A FAM193A NKX2-1 ZNF516 SEC16A TNRC6A CHD6 CUX1 KLC1	5.81e-05	941	123	17	int:KDM1A
Interaction	NUP35 interactions	MATR3 POLRMT CUL7 CREBBP TFAP2A KMT2D RBM27 NKX2-1 SEC16A TNRC6A NUP160	5.86e-05	424	123	11	int:NUP35
Interaction	SEC16A interactions	ELOVL5 AMBRA1 REL MAP7 RCOR1 LATS1 SEC24B SEC16A TNRC6A CHD6 MEX3B	6.11e-05	426	123	11	int:SEC16A
Interaction	YWHAG interactions	NEDD4L MATR3 HJURP CUL7 MAP7 RFX7 WNK1 STAT3 LPIN1 CCDC88A LATS1 SEC24B SEC16A KMT2A NHS AKAP11 SIPA1L2 MEX3B CNOT4 KLC1	6.58e-05	1248	123	20	int:YWHAG
Interaction	MLF1 interactions	TRO BAG4 WNK1 CCDC88A AKAP11 HEATR5B	6.78e-05	113	123	6	int:MLF1
Interaction	ERG interactions	MATR3 UBR4 CREBBP KMT2D ASXL2 KDM6A SLX4 RNF111	6.86e-05	223	123	8	int:ERG
Interaction	KLF15 interactions	TSHZ3 MAP7 CREBBP STAT3 KMT2D ZNF516 SEC16A KDM6A CAPRIN1	7.34e-05	290	123	9	int:KLF15
Interaction	FAM193A interactions	RCOR1 LATS1 FAM193A TNRC6A MEX3B	7.36e-05	71	123	5	int:FAM193A
Interaction	GARRE1 interactions	FAM193A SEC24B SEC16A TNRC6A ASPM SIPA1L2 MEX3B	7.50e-05	167	123	7	int:GARRE1
Interaction	ANKRD17 interactions	RCOR1 HOXC8 FAM193A TNRC6A CAPRIN1 MEX3B SIX2 CNOT4	7.53e-05	226	123	8	int:ANKRD17
Interaction	LATS1 interactions	MATR3 CREBBP COL18A1 CCDC88A LATS1 FAM193A MTF1 SEC24B SEC16A TNRC6A SIPA1L2	8.15e-05	440	123	11	int:LATS1
Interaction	CTBP2 interactions	TSHZ3 FOXP2 ELOVL5 ZFPM1 CUL7 MAP7 TMC3 CREBBP RCOR1 ZNF516	9.19e-05	370	123	10	int:CTBP2
Interaction	MS4A15 interactions	POMT2 LRRC8C ADCY9 SLC12A4	9.21e-05	39	123	4	int:MS4A15
Interaction	EIF4ENIF1 interactions	BAG4 CREBBP RCOR1 SEC16A TNRC6A CAPRIN1 MEX3B CNOT4 RBFOX2	9.51e-05	300	123	9	int:EIF4ENIF1
Interaction	AP2B1 interactions	ACVR1 WNK1 TFAP2A CCDC88A FAM193A SEC16A TNRC6A HEATR5B MEX3B SLX4	9.82e-05	373	123	10	int:AP2B1
Interaction	EYA2 interactions	TFAP2A KMT2D SEC16A TNRC6A KDM6A SIX2	9.92e-05	121	123	6	int:EYA2
Interaction	PAX7 interactions	TSHZ3 CREBBP RCOR1 KMT2D CHD6 KDM6A	1.14e-04	124	123	6	int:PAX7
Interaction	ALG13 interactions	BAG4 KMT2D LATS1 SEC16A TNRC6A MEX3B RBFOX2	1.33e-04	183	123	7	int:ALG13
Interaction	HDAC1 interactions	ZHX3 SIN3B TSHZ3 MATR3 UBR4 POLRMT ZFPM1 CREBBP STAT3 RCOR1 KMT2D NKX2-1 ZNF516 TNRC6A KMT2A CAPRIN1 CUX1 KLC1	1.34e-04	1108	123	18	int:HDAC1
Interaction	YWHAB interactions	NEDD4L MATR3 HJURP CUL7 MAP7 RFX7 WNK1 CCDC88A LATS1 KMT2A NHS AKAP11 ZCCHC7 SIPA1L2 MEX3B CNOT4 KLC1	1.44e-04	1014	123	17	int:YWHAB
Interaction	GLDC interactions	MATR3 BAG4 POLRMT MAP7 RBM27 SEC24B SEC16A TNRC6A CAPRIN1	1.58e-04	321	123	9	int:GLDC
Interaction	FHL2 interactions	SIN3B REL WNK1 CREBBP STAT3 RCOR1 ZFYVE9 RBM27 ASXL2 RNF111	1.60e-04	396	123	10	int:FHL2
Interaction	UBE2I interactions	UBQLN1 TSHZ2 MATR3 FANCM WNK1 CREBBP TFAP2A STAT3 LATS1 NKX2-1 ZCCHC7 SLX4 RNF111	1.83e-04	654	123	13	int:UBE2I
Interaction	GSC interactions	FOXP2 CREBBP KMT2D ZNF516 KDM6A	1.93e-04	87	123	5	int:GSC
Interaction	CTBP1 interactions	TSHZ3 FOXP2 ZFPM1 CREBBP RCOR1 NKX2-1 ZNF516 SEC16A KMT2A RNF111	1.96e-04	406	123	10	int:CTBP1
Interaction	PHLPP1 interactions	SIN3B DDX42 MAP7 CMYA5 STAT3 CCDC88A RBM27 SEC16A ASPM	2.08e-04	333	123	9	int:PHLPP1
Interaction	YWHAE interactions	NEDD4L MATR3 HJURP CUL7 MAP7 WNK1 ANKRD27 LPIN1 CCDC88A LATS1 KMT2A NHS AKAP11 ASXL2 SIPA1L2 CAPRIN1 MEX3B CNOT4 KLC1	2.16e-04	1256	123	19	int:YWHAE
Interaction	MED23 interactions	CDK19 MAP7 CREBBP RCOR1 ZNF516 SEC16A TNRC6A SLX4	2.31e-04	266	123	8	int:MED23
Interaction	GJA1 interactions	VEZT ELOVL5 FAM171B ADCY9 SIDT2 CCDC88A ZFYVE9 SLC12A4 SEC24B SEC16A SIPA1L2 ADGRL2	2.38e-04	583	123	12	int:GJA1
Interaction	DYRK1B interactions	RFX7 CREBBP ZNF516 AKAP11 SIPA1L2	2.39e-04	91	123	5	int:DYRK1B
Interaction	HDAC2 interactions	ZHX3 SIN3B MATR3 ZFPM1 CUL7 WNK1 CREBBP STAT3 RCOR1 ZNF516 CNTNAP2 KMT2A KDM6A CAPRIN1 CNOT4	2.55e-04	865	123	15	int:HDAC2
Interaction	MSH6 interactions	MATR3 CUL7 CREBBP DICER1 RCOR1 KDM6A CAPRIN1 SLX4	2.62e-04	271	123	8	int:MSH6
Interaction	CNOT6L interactions	FAM193A SEC16A TNRC6A MEX3B CNOT4	2.64e-04	93	123	5	int:CNOT6L
Interaction	PPHLN1 interactions	MATR3 CUL7 MAP7 ZNF677 LATS1 SLX4	2.76e-04	146	123	6	int:PPHLN1
Interaction	NAA40 interactions	ZHX3 SIN3B MATR3 DDX42 CAST WNK1 STAT3 WAC FAM193A RBM27 SEC24B SEC16A MASTL KMT2A SIPA1L2 KLC1	3.02e-04	978	123	16	int:NAA40
Interaction	AR interactions	ZHX3 SIN3B MATR3 DDX42 REL CREBBP TFAP2A STAT3 WAC RCOR1 KMT2D RBM27 SEC16A KMT2A KDM6A CUX1	3.53e-04	992	123	16	int:AR
Interaction	DEFA6 interactions	UBQLN1 ZFPM1 ZFYVE9	3.59e-04	23	123	3	int:DEFA6
Interaction	SOX2 interactions	SIN3B TSHZ3 MATR3 UBR4 HJURP CUL7 TFAP2A RCOR1 KMT2D SEC16A TNRC6A KMT2A SGO2 AKAP11 CHD6 SIPA1L2 KDM6A CAPRIN1 CUX1 RBFOX2	3.76e-04	1422	123	20	int:SOX2
Interaction	SMAD6 interactions	NEDD4L ACVR1 HOXC8 RNF111	3.80e-04	56	123	4	int:SMAD6
Interaction	WNK3 interactions	NEDD4L REL WNK1 SEC16A	3.80e-04	56	123	4	int:WNK3
Interaction	TPRX2 interactions	CREBBP RCOR1 KMT2D KDM6A	3.80e-04	56	123	4	int:TPRX2
Interaction	HSPB1 interactions	ANK1 MATR3 CAST AMBRA1 CREBBP ADCY9 STAT3 TGM1 RCOR1 LATS1 SEC16A SLX4 KLC1	3.93e-04	708	123	13	int:HSPB1
Interaction	GSTO2 interactions	CREBBP TFAP2A HOXC8	4.09e-04	24	123	3	int:GSTO2
Interaction	STX6 interactions	VEZT FAM171B ADCY9 CCDC88A ZFYVE9 SLC12A4 SEC24B SEC16A ADGRL2 CUX1	4.27e-04	448	123	10	int:STX6
Interaction	NFE2L2 interactions	REL CREBBP STAT3 WAC CHD6 RNF111	4.36e-04	159	123	6	int:NFE2L2
Interaction	DCP1B interactions	BAG4 LATS1 SEC16A TNRC6A MEX3B	4.43e-04	104	123	5	int:DCP1B
Interaction	KLF4 interactions	CREBBP RCOR1 KMT2D ZNF516 KDM6A CUX1	4.51e-04	160	123	6	int:KLF4
Interaction	RAD50 interactions	ATXN7L1 MATR3 CUL7 CREBBP STAT3 RCOR1 TBCK SLX4 KLC1	4.59e-04	371	123	9	int:RAD50
Interaction	SIRT6 interactions	MATR3 POLRMT AMBRA1 CREBBP DICER1 WAC RBM27 SEC16A SGO2 CAPRIN1 NUP160 SLX4	4.66e-04	628	123	12	int:SIRT6
Interaction	FOXK2 interactions	SIN3B UBR4 RCOR1 KMT2D ASXL2 KDM6A CUX1	4.68e-04	225	123	7	int:FOXK2
Interaction	DCP1A interactions	BAG4 RCOR1 LATS1 SEC16A TNRC6A MEX3B	5.48e-04	166	123	6	int:DCP1A
Interaction	CEBPA interactions	ZHX3 SIN3B UBQLN1 MATR3 CREBBP TFAP2A WAC RCOR1 KMT2D RBM27 ZNF516 KMT2A BICRAL ASXL2 KDM6A CAPRIN1 NUP160 CUX1	5.51e-04	1245	123	18	int:CEBPA
Interaction	EN1 interactions	KMT2D KMT2A ASXL2 KDM6A CUX1	5.73e-04	110	123	5	int:EN1
Interaction	MAFA interactions	STAT3 KMT2D KDM6A	5.83e-04	27	123	3	int:MAFA
Interaction	ANAPC2 interactions	CREBBP ADCY9 FAM193A TNRC6A SIPA1L2 CUX1 KLC1	5.90e-04	234	123	7	int:ANAPC2
Interaction	PAX8 interactions	CREBBP KMT2D HOXC8 NKX2-1 KDM6A	5.97e-04	111	123	5	int:PAX8
Interaction	CEP85 interactions	LATS1 FAM193A SEC16A TNRC6A MASTL MEX3B	6.02e-04	169	123	6	int:CEP85
Interaction	OTUD4 interactions	UBL7 REL LATS1 TNRC6A CAPRIN1 MEX3B RBFOX2	6.21e-04	236	123	7	int:OTUD4
Interaction	EGR2 interactions	FOXP2 CREBBP KMT2D SEC16A KMT2A KDM6A	6.40e-04	171	123	6	int:EGR2
Interaction	ZNF750 interactions	TFAP2A RCOR1 ZNF516	6.50e-04	28	123	3	int:ZNF750
Interaction	GABRA3 interactions	POMT2 UBQLN1 SIDT2	6.50e-04	28	123	3	int:GABRA3
Interaction	CSNK1E interactions	FOXP2 DDX42 USP9Y LPIN1 CNTNAP2 SEC16A SGO2 SLX4	6.52e-04	311	123	8	int:CSNK1E
Interaction	AMOT interactions	NEDD4L UBR4 RCOR1 LATS1 FAM193A SEC16A TNRC6A SIPA1L2	6.66e-04	312	123	8	int:AMOT
Interaction	ZNF550 interactions	REL SBSN TGM1 CRNN	6.71e-04	65	123	4	int:ZNF550
Interaction	AKAP8L interactions	MATR3 AMBRA1 RCOR1 LATS1 CNTNAP2 SEC16A SLX4	6.86e-04	240	123	7	int:AKAP8L
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 TSHZ3 TSHZ2	4.08e-05	15	83	3	529
GeneFamily	Ataxins\|Trinucleotide repeat containing	FOXP2 KMT2D TNRC6A	1.99e-04	25	83	3	775
GeneFamily	Regulatory factor X family	RFX8 RFX7	5.73e-04	8	83	2	1153
GeneFamily	X-linked mental retardation\|RNA helicases	FANCM DICER1	1.11e-03	11	83	2	1168
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX3 TSHZ3 TSHZ2 ZFPM1 ZNF236 ZXDA ZXDB ZNF677 ZNF516 KLF17	1.63e-03	718	83	10	28
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	FANCM SLX4	3.75e-03	20	83	2	548
GeneFamily	CD molecules\|Mucins	MUC15 MUC16	4.13e-03	21	83	2	648
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZHX3 CDK19 DDX42 ACVR1 REV3L CREBBP DICER1 ADCY9 RCOR1 FAM193A ZFYVE9 SEC24B AKAP11 BICRAL NUP160 CNOT4 CUX1 RBFOX2 KLC1	2.49e-08	856	125	19	M4500
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	UBL7 POMT2 TSHZ3 ACVR1 WNK1 CREBBP DICER1 KIAA1614 ADCY9 STAT3 ZXDB COL18A1 ADAMTS15 CHD6 TMEM123 CAPRIN1 MEX3B NUP160 CUX1	3.20e-07	1009	125	19	M157
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	MATR3 UBR4 AOAH ELOVL5 REV3L RFX7 WNK1 CREBBP DICER1 STAT3 WAC LPIN1 KMT2D CCDC88A LATS1 RBM27 KMT2A PCNX1 AKAP11 ASXL2 TMEM123 KLC1	2.11e-06	1492	125	22	M40023
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	SIN3B ELOVL5 RFX7 WNK1 CREBBP WAC RCOR1 RBM27 TNRC6A SIPA1L2 RBFOX2 RNF111	2.54e-06	467	125	12	M1347
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	SIN3B ELOVL5 RFX7 WNK1 CREBBP WAC RCOR1 RBM27 TNRC6A SIPA1L2 RBFOX2 RNF111	3.67e-06	484	125	12	MM999
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	ANK1 NEDD4L FOXP2 TSHZ2 SLC22A15 KCTD8 REV3L LPIN1 CCDC88A KCND2 BICRAL RBFOX2 KLC1	4.58e-06	584	125	13	M39068
Coexpression	GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP	SIN3B ANK1 MATR3 DDX42 CAST TTBK2 SIDT2 KMT2D	5.28e-06	199	125	8	M3257
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	UBL7 POMT2 TSHZ3 ACVR1 WNK1 DICER1 KIAA1614 STAT3 ZXDB ADAMTS15 CAPRIN1	8.42e-06	438	125	11	M227
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	LRRC8C ANK1 TSHZ2 KCTD8 REV3L FAM171B DICER1 LPIN1 CCDC88A KCND2 CNTNAP2 RBFOX2 KLC1	3.24e-05	703	125	13	M39070
Coexpression	LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB	ZHX3 FOXP2 WNK1 TBCK TNRC6A NHS	4.01e-05	131	125	6	M39232
Coexpression	GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN	ANK1 REL DICER1 ANKRD27 STAT3 WAC KDM6A	4.75e-05	198	125	7	M3248
Coexpression	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN	TSHZ3 AOAH SBSN ZXDB LPIN1 SEC16A CNOT4	4.90e-05	199	125	7	M3583
Coexpression	GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN	ILRUN SIN3B ZFPM1 SIDT2 KCND2 PCNX1 CUX1	5.06e-05	200	125	7	M7209
Coexpression	HU_FETAL_RETINA_BIPOLAR	LRTM1 FAM171B MAP7 CCDC88A RP1	6.15e-05	87	125	5	M39262
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ZHX3 ACVR1 REV3L CREBBP RCOR1 ZFYVE9 SEC24B CNOT4 CUX1 RBFOX2	8.22e-05	466	125	10	M13522
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	ATXN7L1 CREBBP DICER1 KMT2D TNRC6A ASXL2	1.09e-04	157	125	6	M7733
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	ZHX3 NEDD4L FOXP2 MUC15 REV3L FAM171B TFAP2A LATS1 FAM193A ADAMTS15 ASXL2 CAPRIN1 SIX2 CUX1 RBFOX2 PYGO1	1.60e-09	407	122	16	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	ZHX3 FOXP2 REV3L LATS1 FAM193A ASXL2 CAPRIN1 CUX1 RBFOX2	2.01e-07	149	122	9	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	ZHX3 FOXP2 VEZT MUC15 REV3L FAM171B TFAP2A LATS1 FAM193A ASPM ADAMTS15 ASXL2 CAPRIN1 MEX3B SIX2 CUX1 RBFOX2 PYGO1	8.15e-07	806	122	18	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	ZHX3 NEDD4L FOXP2 ATXN7L1 MUC15 ACVR1 REV3L FAM171B TFAP2A LATS1 FAM193A ADAMTS15 ASXL2 CAPRIN1 SIX2 CUX1 RBFOX2 PYGO1	8.15e-07	806	122	18	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	ZHX3 FOXP2 VEZT REV3L FAM171B LATS1 FAM193A ASPM ASXL2 CAPRIN1 CUX1 RBFOX2	1.48e-06	369	122	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	FOXP2 VEZT REV3L FAM171B CREBBP LATS1 ASPM ASXL2 CAPRIN1 CUX1 RBFOX2	3.27e-06	330	122	11	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	ZHX3 FOXP2 MUC15 REV3L FAM171B TFAP2A LATS1 ASPM ADAMTS15 ASXL2 CUX1 RBFOX2	4.17e-06	408	122	12	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	FOXP2 VEZT MUC15 GPR87 ACVR1 RFX7 TFAP2A ZXDB TTBK2 CCDC88A LATS1 ADAMTS15 SGO2 ASXL2 MEX3B CUX1 PYGO1	5.94e-06	836	122	17	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	FOXP2 VEZT MUC15 GPR87 ACVR1 FAM171B RFX7 TFAP2A ZXDB TTBK2 CCDC88A ADAMTS15 SGO2 ASXL2 KDM6A CUX1 PYGO1	7.38e-06	850	122	17	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	ZHX3 FOXP2 ACVR1 REV3L LATS1 FAM193A ASXL2 CAPRIN1 CUX1 RBFOX2	1.31e-05	312	122	10	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	FOXP2 VEZT ACVR1 REV3L WNK1 FAM193A SEC24B ASXL2 CAPRIN1 CUX1 RBFOX2	1.40e-05	385	122	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	ZHX3 FOXP2 REV3L LATS1 ASPM ASXL2 CUX1 RBFOX2	1.66e-05	194	122	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	ZHX3 FOXP2 VEZT MUC15 REV3L FAM171B CREBBP TFAP2A LATS1 KCND2 ASPM ADAMTS15 ASXL2 CAPRIN1 CUX1 RBFOX2	1.85e-05	818	122	16	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500	FOXP2 MUC15 GPR87 ACVR1 RFX7 TFAP2A ZXDB TTBK2 ASXL2 CUX1 PYGO1	3.71e-05	428	122	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5	NEDD4L HJURP SLC22A15 ACVR1 FAM171B STAT3 HOXC8 CNTNAP2 NHS CHD6 TMEM123 SIPA1L2 ADGRL2 PYGO1	7.01e-05	722	122	14	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000	ZHX3 FOXP2 VEZT CREBBP LATS1 CUX1 RBFOX2	7.70e-05	178	122	7	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ILRUN REV3L DICER1 CCDC88A LATS1 FAM193A ASPM KDM6A CUX1	7.92e-05	311	122	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_100	REV3L CUX1 RBFOX2	1.19e-04	17	122	3	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100	FOXP2 REV3L TFAP2A CUX1 RBFOX2	1.38e-04	86	122	5	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500	FOXP2 FAM171B TFAP2A ADAMTS15 SIX2 PYGO1	1.42e-04	137	122	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	REV3L KIAA1614 WAC RCOR1 CCDC88A LATS1 FAM193A ZCCHC7 SIPA1L2 HEATR5B KDM6A SLX4 CNOT4 CUX1	1.58e-04	780	122	14	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ILRUN NEDD4L REV3L MAP7 DICER1 TTBK2 CCDC88A HOXC8 LATS1 FAM193A NKX2-1 CNTNAP2 ASPM TMEM123 KDM6A CUX1	1.73e-04	989	122	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000	ACVR1 REV3L ASPM ASXL2 CNOT4 CUX1 RBFOX2	1.74e-04	203	122	7	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	TSHZ2 HJURP DDX42 FAM171B CREBBP STAT3 HOXC8 KCND2 TNRC6A ASPM KDM6A MEX3B CNOT4 RBFOX2	1.80e-04	790	122	14	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_100	REV3L CUX1 RBFOX2	1.96e-04	20	122	3	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	ZHX3 VEZT REV3L FAM193A ASXL2 CUX1 RBFOX2	2.08e-04	209	122	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	NEDD4L FOXP2 GPR87 REV3L FAM171B FANCM TFAP2A DICER1 WAC CCDC88A HOXC8 FAM193A RBM27 CNTNAP2 ASPM MASTL SGO2 MEX3B CNOT4 CUX1	2.39e-04	1459	122	20	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000	ZHX3 FOXP2 TEK LATS1 ASXL2 CUX1	2.40e-04	151	122	6	gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200	FOXP2 REV3L CUX1 RBFOX2	2.44e-04	53	122	4	gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	FOXP2 VEZT MUC15 ACVR1 REV3L FAM171B WNK1 TFAP2A FAM193A SEC24B ASXL2 CAPRIN1 CUX1 RBFOX2	2.57e-04	818	122	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	NEDD4L FOXP2 GPR87 REV3L FAM171B FANCM DICER1 WAC CCDC88A FAM193A RBM27 CNTNAP2 ASPM MASTL SGO2 MEX3B CNOT4 CUX1	3.00e-04	1257	122	18	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	VEZT REV3L FAM193A SEC24B ASXL2 CAPRIN1 CNOT4 CUX1 RBFOX2	3.47e-04	379	122	9	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500	FOXP2 VEZT LATS1 ASXL2 CUX1 RBFOX2	3.86e-04	165	122	6	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200	FOXP2 REV3L FAM171B TFAP2A CUX1 RBFOX2	3.86e-04	165	122	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NEDD4L SLC22A15 ACVR1 FAM171B LATS1 RBM27 ASPM NHS CHD6 TMEM123 SIPA1L2 CUX1	3.90e-04	654	122	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	FOXP2 MUC15 TFAP2A LATS1 CUX1 RBFOX2	4.53e-04	170	122	6	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	ZHX3 VEZT MUC15 SLC22A15 GPR87 REV3L FAM171B TFAP2A TGM1 FAM193A ASXL2 CUX1 RBFOX2	4.85e-04	769	122	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	ZHX3 FOXP2 HJURP LATS1 ASPM ASXL2 CAPRIN1 CUX1 RBFOX2	4.85e-04	397	122	9	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	NEDD4L HJURP FAM171B MAP7 FANCM HOXC8 LATS1 RBM27 CNTNAP2 ASPM NHS CHD6 TMEM123 SIPA1L2 CUX1	5.19e-04	983	122	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	HJURP FMR1NB WNK1 CREBBP STAT3 ZXDB KCND2 TNRC6A ASXL2 ZCCHC7 KDM6A MEX3B CNOT4	5.40e-04	778	122	13	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500	MUC15 ACVR1 RFX7 ZXDB TTBK2 ASXL2 PYGO1	5.98e-04	249	122	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NEDD4L FAM171B LATS1 RBM27 ASPM TMEM123 SIPA1L2 CUX1	6.24e-04	328	122	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_500	MUC15 MAP7 TFAP2A TGM1 PADI3	6.25e-04	119	122	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k5
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	TSHZ2 MUC16 ACVR1 REV3L TMC3 SBSN RCOR1 HOXC8 KCND2 ASPM MASTL NHS SGO2	6.46e-04	793	122	13	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	VEZT REV3L CUX1 RBFOX2	6.72e-04	69	122	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	TSHZ2 MATR3 HJURP DDX42 CREBBP STAT3 HOXC8 TNRC6A ASPM KDM6A MEX3B CNOT4 RBFOX2	7.08e-04	801	122	13	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	ZHX3 FOXP2 VEZT MUC15 FAM171B LATS1 ASXL2 CUX1 RBFOX2	8.15e-04	427	122	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500	FOXP2 MUC15 GPR87 RFX7 ZXDB TTBK2 ASXL2 CUX1 PYGO1	8.42e-04	429	122	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	ZHX3 FOXP2 VEZT TRO HJURP ACVR1 TTBK2 HOXC8 KCND2 ADAMTS15 SGO2 ADGRL2 PYGO1	8.69e-04	819	122	13	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	ILRUN FOXP2 TRO REV3L WNK1 WAC RCOR1 ASXL2 HEATR5B	8.84e-04	432	122	9	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100	REV3L CUX1 RBFOX2	8.90e-04	33	122	3	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200	FOXP2 LATS1 CUX1 RBFOX2	9.20e-04	75	122	4	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500	UBL7 ILRUN UBQLN1 SEC24B CAPRIN1 MEX3B CUX1 RBFOX2 KLC1	9.28e-04	435	122	9	gudmap_developingGonad_e11.5_testes and mesonephros_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	ZHX3 TSHZ3 FOXP2 VEZT MUC15 TEK CREBBP LATS1 ADAMTS15 SGO2 MEX3B CUX1 RBFOX2	9.39e-04	826	122	13	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200	FOXP2 ASXL2 CUX1 RBFOX2	1.07e-03	78	122	4	gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500	ZHX3 REV3L CAPRIN1 CNOT4 CUX1 RBFOX2	1.09e-03	201	122	6	gudmap_developingKidney_e15.5_500_k3
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	UBL7 ILRUN UBQLN1 FOXP2 STAT3 WAC HOXC8 SEC24B CAPRIN1 MEX3B CUX1 RBFOX2 KLC1	1.14e-03	844	122	13	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_100	FOXP2 CUX1 RBFOX2	1.15e-03	36	122	3	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_100
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC15 MUC16 GPR87 CMYA5 TFAP2A TGM1 NKX2-1 RBFOX2	7.30e-08	192	125	8	8899d81306770adda893b5e146df1253971754c5
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC15 MUC16 GPR87 CMYA5 TFAP2A TGM1 NKX2-1 RBFOX2	7.30e-08	192	125	8	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MATR3 AMBRA1 RCOR1 PCNX1 KDM6A CUX1 RBFOX2 RNF111	7.60e-08	193	125	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ZHX3 MATR3 REL CREBBP CNTNAP2 ZCCHC7 HEATR5B	5.12e-07	169	125	7	c3a6179a64589a370108fea809b157839347759c
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L FOXP2 AMBRA1 RFX7 ADCY9 ZCCHC7 RBFOX2	1.38e-06	196	125	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L FOXP2 AMBRA1 ADCY9 KDM6A CUX1 RBFOX2	1.48e-06	198	125	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	FOXP2 AMBRA1 RFX7 TNRC6A ZCCHC7 KDM6A RBFOX2	1.53e-06	199	125	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Basal_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	TSHZ3 GPR87 CMYA5 RFX8 TFAP2A NHS	4.54e-06	152	125	6	72499e4d2b374ef5f1621c89d94727ecf4bd4d5d
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TSHZ3 GPR87 TFAP2A COL18A1 CNTNAP2 SIX2	9.21e-06	172	125	6	bb542f6ca4eb8167129bc84ca1160a54fbb68731
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TSHZ3 GPR87 TFAP2A COL18A1 CNTNAP2 SIX2	9.21e-06	172	125	6	aff37b9689b0d30ee7097d997d9588efc475c8fd
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 MATR3 CAST CMYA5 CCDC88A KDM6A	1.05e-05	176	125	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ANK1 TSHZ2 MAP7 F5 NHS SIPA1L2	1.12e-05	178	125	6	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CEACAM5 MUC15 TGM1 NKX2-1 RP1 PYGO1	1.27e-05	182	125	6	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATR3 REL CCDC88A KMT2A ZCCHC7 KDM6A	1.35e-05	184	125	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPR87 CMYA5 RFX8 TFAP2A KIAA1614 RBFOX2	1.48e-05	187	125	6	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	CEACAM5 NEDD4L FOXP2 MUC16 MAP7 NHS	1.62e-05	190	125	6	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TSHZ3 TSHZ2 REV3L STAT3 COL18A1 NHS	1.67e-05	191	125	6	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Club_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM5 NEDD4L MUC16 GPR87 TFAP2A NKX2-1	1.77e-05	193	125	6	6582c0367052b9d10fb629c383ee0c55872afd2d
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	FOXP2 TSHZ2 REV3L STAT3 COL18A1 KCND2	1.77e-05	193	125	6	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	Club_cells\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM5 NEDD4L MUC16 GPR87 TFAP2A NKX2-1	1.77e-05	193	125	6	9d3165dc5763a07a7d873f497624d9d6528fa2db
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAG4 GPR87 SBSN TGM1 CRNN ADGRL2	1.82e-05	194	125	6	bd94d30584128628b34ed8c3857ce103586cfe2e
ToppCell	NS-critical-d_07-13-Epithelial-Squamous\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEACAM5 SBSN LPIN1 TGM1 CRNN PADI3	1.82e-05	194	125	6	53a34843d529ef395deb27086f71f7049a087bab
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte-new-cluster\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAG4 GPR87 SBSN TGM1 CRNN ADGRL2	1.82e-05	194	125	6	b847c5b4e8914b1c306bfff3d7119c32063784a8
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRO KCTD8 CMYA5 ZXDA TGM1 ADAMTS15	1.88e-05	195	125	6	a52685f76eca269a7d2de8dfc317439483e233fa
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRO KCTD8 CMYA5 ZXDA TGM1 ADAMTS15	1.88e-05	195	125	6	224deeba2f60def6543a55bb4f5ee6c7fdab3f02
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-INs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	LRTM1 ACVR1 CCDC88A TMEM123 MEX3B RBFOX2	1.93e-05	196	125	6	556e18eae05bf19259fe02848bcc9120aa2a9d29
ToppCell	distal-1-mesenchymal-Mesothelial\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KCTD8 MUC16 CMYA5 SBSN TGM1 CNTNAP2	2.10e-05	199	125	6	8dd5b411d2f1626830b77a1616cc3fb67dc59338
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	FOXP2 TSHZ2 MUC16 CMYA5 TFAP2A NHS	2.16e-05	200	125	6	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	FOXP2 LRTM1 TFAP2A CCDC88A CNTNAP2 RBFOX2	2.16e-05	200	125	6	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	NEDD4L FOXP2 TFAP2A CCDC88A RBFOX2 KLC1	2.16e-05	200	125	6	68c90376e2779434e4ad8dc6dd3b44baa700e2f4
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal\|10w / Sample Type, Dataset, Time_group, and Cell type.	NEDD4L FOXP2 TFAP2A CCDC88A RBFOX2 KLC1	2.16e-05	200	125	6	979258173b82f37aeaaedd53b4a527da1dbe1b80
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	MATR3 SLC22A15 LRTM1 F5 ZFYVE9	2.44e-05	122	125	5	a2f343962069253a08faa80fd70723b8488a99ec
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	CEACAM5 PCDHGA1 BAG4 MAP7 RFX7	3.56e-05	132	125	5	48449e2e95804a26f204ac7ea763dee26cf794ab
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FOXP2 TSHZ2 MC3R F5	4.03e-05	68	125	4	cdb805182f7169fbc3bec31adec3a4e088281757
ToppCell	Mild/Remission-B_naive-4\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ZHX3 MATR3 REL CNTNAP2 ZCCHC7	6.15e-05	148	125	5	dd5e1bc02824e743e1c030a303e32f27a359a8ca
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	GPR87 TFAP2A TGM1 CNTNAP2 SIX2	8.88e-05	160	125	5	18ae6822915d16699beb9047baeef9b006901a35
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	GPR87 TFAP2A TGM1 CNTNAP2 SIX2	8.88e-05	160	125	5	830f17bad94de05612fe6d53d39e42a4b3f3e2f3
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ANK1 KCTD8 NKX2-1 NHS CHD6	9.15e-05	161	125	5	b81b346309f3facbfbebd91cae4c5b33c7bd24ef
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	LRRC8C USP9Y STAT3 PCNX1 KDM6A	9.42e-05	162	125	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MATR3 SLC22A15 LRTM1 AMBRA1 ZFYVE9	1.06e-04	166	125	5	f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2
ToppCell	Basal_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	GPR87 TFAP2A CNTNAP2 CRNN SIX2	1.06e-04	166	125	5	23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCell	10x5'-Liver-Hematopoietic_progenitors\|Liver / Manually curated celltypes from each tissue	HJURP FANCM CCDC88A ASPM NHS	1.06e-04	166	125	5	ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCell	10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Liver / Manually curated celltypes from each tissue	HJURP FANCM CCDC88A ASPM NHS	1.06e-04	166	125	5	a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell	droplet-Thymus-nan-3m-Myeloid-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	REL CMYA5 ADCY9 C14orf132 TMEM123	1.06e-04	166	125	5	c0af93db981dfd448abc7efcd257f3e5ff066aae
ToppCell	Control-Epithelial-Mesothelial\|Control / Disease state, Lineage and Cell class	KCTD8 LRTM1 MUC16 TGM1 SIX2	1.06e-04	166	125	5	1ed3788257e14f097862b999f020bfe2a57de52b
ToppCell	Frontal_cortex-Neuronal-Inhibitory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ANK1 CNTNAP2 TNRC6A NHS CHD6	1.15e-04	169	125	5	78eb70dd916724e476eabccf18fb7fcec4210308
ToppCell	Dividing_Macrophages-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	HJURP CCDC88A ASPM MASTL SGO2	1.15e-04	169	125	5	bc859a103cad567caf50c3c3882d2d2017807c73
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HJURP COL18A1 ASPM MASTL SGO2	1.21e-04	171	125	5	621f9da0bfa09c86fc89fd26919403e94cd56d2b
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC88A HOXC8 ASPM MASTL SGO2	1.32e-04	174	125	5	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	USP9Y WNK1 TFAP2A COL18A1 ADGRL2	1.43e-04	177	125	5	c9e8149639551a4c8daa90fcb2b895fdcff2e2ba
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 TSHZ2 CUL7 TEK TTBK2	1.50e-04	179	125	5	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCTD8 MUC16 TGM1 ASPM SGO2	1.58e-04	181	125	5	3dcb74b28f93be35ddf4de1937f7e30b25e11927
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KCTD8 MUC16 TGM1 ASPM SGO2	1.58e-04	181	125	5	7679a5980011d6dfb1aaca7abf678c29b6f819bb
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK1 HJURP GPR87 CNTNAP2 ASPM	1.67e-04	183	125	5	d4aa21ba4f6f92e25ecff80b7399bca31527fd7e
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	NEDD4L GPR87 MAP7 TFAP2A NHS	1.67e-04	183	125	5	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TSHZ2 REV3L TEK STAT3 PYGO1	1.71e-04	184	125	5	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic\|lymph-node_spleen / Manually curated celltypes from each tissue	FOXP2 HJURP CCDC88A ASPM MEX3B	1.75e-04	185	125	5	912d8efdc37820dbb07736221a98af929e5a7c97
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSHZ2 CUL7 TEK UNC5A ZNF516	1.75e-04	185	125	5	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PDE4A NEDD4L CUL7 FANCM RCOR1	1.80e-04	186	125	5	bca5215d406f1785bf3a420201d5686071fcaca5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AOAH HJURP CCDC88A ASPM SGO2	1.84e-04	187	125	5	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	NEDD4L GPR87 MAP7 TFAP2A NHS	1.84e-04	187	125	5	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD8 WNK1 TFAP2A COL18A1 ADGRL2	1.84e-04	187	125	5	b7689e7f6511920cd2beff27389555fddf685f61
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	REL RCOR1 KMT2A PCNX1 KDM6A	1.89e-04	188	125	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	NEDD4L FOXP2 MAP7 NKX2-1 RP1	1.89e-04	188	125	5	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CEACAM5 MUC15 MUC16 GPR87 PADI3	1.89e-04	188	125	5	07705bed928683470a52c8ccfa40ffb9a0971318
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HJURP TFAP2A UNC5A ASPM SGO2	1.94e-04	189	125	5	815afad947ed77a8b03724bf78014799fed34f54
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A15 KCTD8 WNK1 TFAP2A ADGRL2	1.94e-04	189	125	5	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KCND2 ASPM ADAMTS15 NHS	1.94e-04	189	125	5	99a13b1b669b0cd36e3096632351d9ade25d1173
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	NEDD4L FOXP2 MAP7 TFAP2A NHS	1.94e-04	189	125	5	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A15 KCTD8 WNK1 TFAP2A ADGRL2	1.94e-04	189	125	5	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NEDD4L FOXP2 AMBRA1 ADAMTS15 RP1	1.94e-04	189	125	5	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSHZ3 ANK1 CNTNAP2 NHS PYGO1	1.98e-04	190	125	5	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 KCTD8 KCND2 ASPM NHS	1.98e-04	190	125	5	8c9c230a509afaeee50644153974a5642b01a2b8
ToppCell	facs-Lung-EPCAM-24m-Epithelial-Neuroendocrine\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRO LRTM1 FAM171B F5 NKX2-1	2.03e-04	191	125	5	501d4f6ad389d9ac5051d4247b9bd3da96f713f9
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HJURP MAP7 NKX2-1 ASPM SGO2	2.03e-04	191	125	5	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	TRO GPR87 TFAP2A COL18A1 NHS	2.03e-04	191	125	5	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEDD4L FOXP2 MAP7 NKX2-1 RP1	2.03e-04	191	125	5	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	facs-Lung-EPCAM-24m-Epithelial-lung_neuroendocrine_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRO LRTM1 FAM171B F5 NKX2-1	2.03e-04	191	125	5	8e06cc61eaff1796c2ce014074029408ba88d561
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HJURP MAP7 NKX2-1 ASPM SGO2	2.08e-04	192	125	5	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	WNK1 TBCK TNRC6A CHD6 KDM6A	2.08e-04	192	125	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TSHZ2 STAT3 KMT2A PCNX1 KDM6A	2.08e-04	192	125	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	NEDD4L FOXP2 MAP7 NKX2-1 RBFOX2	2.08e-04	192	125	5	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEDD4L FOXP2 WNK1 NKX2-1 CUX1	2.13e-04	193	125	5	54506c0da2f219f472b95e8935a78b657a8dec41
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK1 CNTNAP2 ASPM NHS PYGO1	2.13e-04	193	125	5	9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZXDA LATS1 PCNX1 ASXL2 CAPRIN1	2.13e-04	193	125	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEDD4L MAP7 CMYA5 NHS CUX1	2.13e-04	193	125	5	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	NEDD4L TSHZ2 F5 TNRC6A CHD6	2.13e-04	193	125	5	503a979328c68b096680b71359a26f02fafdff35
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEDD4L MAP7 CMYA5 NHS CUX1	2.13e-04	193	125	5	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEDD4L FOXP2 WNK1 NKX2-1 CUX1	2.13e-04	193	125	5	2d42721fac1bee294ede47d609bebb3e7d36bf0c
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	WNK1 TBCK TNRC6A CHD6 KDM6A	2.13e-04	193	125	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE4C HJURP CCDC88A ASPM MASTL	2.13e-04	193	125	5	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 ANK1 NEDD4L FOXP2 CUX1	2.13e-04	193	125	5	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	18-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	GPR87 TFAP2A NKX2-1 TMEM123 SIX2	2.13e-04	193	125	5	5067b0db24f96e26cf3f9437736415f694e7a614
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	LRTM1 REV3L CCDC88A CNTNAP2 RBFOX2	2.18e-04	194	125	5	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	LRTM1 REV3L CCDC88A CNTNAP2 RBFOX2	2.18e-04	194	125	5	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	HJURP MAP7 NKX2-1 ASPM SGO2	2.18e-04	194	125	5	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	TSHZ2 KCTD8 MUC16 REL TGM1	2.18e-04	194	125	5	784b15119c91ace33d34bfb3d68c182566a3e9a8
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRC8C TEK SIPA1L2 ADGRL2 RBFOX2	2.18e-04	194	125	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEDD4L FOXP2 MAP7 ADCY9 NKX2-1	2.18e-04	194	125	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TSHZ2 STAT3 COL18A1 PCNX1 TMEM123	2.24e-04	195	125	5	e4caa01d2040a6f4dd90e68c2e1e99c5405e2eba
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	CDK19 HJURP AMBRA1 REV3L MAP7 CREBBP ADCY9 ADGRL2 KDM6A CNOT4	4.04e-08	174	124	10	7530_DN
Drug	DAPH; Down 200; 10uM; MCF7; HG-U133A	ILRUN REV3L MAP7 ANKRD27 LPIN1 SIDT2 FAM193A TMEM123 RBFOX2 RNF111	1.30e-07	197	124	10	624_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	HJURP ACVR1 REV3L CREBBP WAC SEC24B ASPM CNOT4 RNF111	7.05e-07	182	124	9	3887_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	REV3L TFAP2A DICER1 FAM193A SEC24B KMT2A CNOT4 CUX1 RNF111	8.08e-07	185	124	9	1114_DN
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	NEDD4L GPR87 REL ADCY9 LPIN1 KMT2A PCNX1 KDM6A	4.32e-06	170	124	8	4680_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	HJURP REV3L MAP7 CREBBP RCOR1 SEC24B CAPRIN1 CNOT4	7.44e-06	183	124	8	7498_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	ILRUN PDE4C REL WNK1 LPIN1 KMT2A PCNX1 RBFOX2	9.06e-06	188	124	8	4545_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	SIN3B VEZT ATXN7L1 REL WNK1 SIDT2 HOXC8 PCNX1	9.79e-06	190	124	8	4582_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	ILRUN PDE4C WNK1 DICER1 SIDT2 CCDC88A PCNX1 CNOT4	9.79e-06	190	124	8	4307_DN
Drug	Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A	POMT2 ZHX3 MC3R CUL7 WNK1 LPIN1 KMT2D CNOT4	1.14e-05	194	124	8	6457_UP
Drug	Norethindrone [68-22-4]; Down 200; 13.4uM; HL60; HT_HG-U133A	PDE4A CAST ELOVL5 ZNF236 ADCY9 CNOT4 RBFOX2 KLC1	1.23e-05	196	124	8	2383_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A	ZHX3 NEDD4L WNK1 LPIN1 TTBK2 ZFYVE9 PCNX1 BICRAL	1.27e-05	197	124	8	5999_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A	ZHX3 NEDD4L ZNF236 WNK1 TFAP2A SIDT2 ZFYVE9 CNTNAP2	1.37e-05	199	124	8	5449_UP
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	UBR4 CDK19 WAC KMT2A PCNX1 KDM6A CNOT4	2.81e-05	160	124	7	4404_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	HJURP CREBBP WAC RCOR1 SEC24B CNOT4 RNF111	5.94e-05	180	124	7	4541_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	HJURP CREBBP RCOR1 SEC24B ASPM CNOT4 RNF111	6.82e-05	184	124	7	2321_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	RFX7 WNK1 CNTNAP2 KMT2A PCNX1 KDM6A CNOT4	8.35e-05	190	124	7	4322_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	ILRUN VEZT WNK1 DICER1 CCDC88A HOXC8 PCNX1	8.62e-05	191	124	7	4283_DN
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	PDE4A RFX7 WNK1 DICER1 SIDT2 CNTNAP2 PCNX1	8.62e-05	191	124	7	4273_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	VEZT WNK1 TFAP2A LPIN1 PCNX1 CAPRIN1 CNOT4	8.62e-05	191	124	7	4298_DN
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	ZHX3 UBR4 CDK19 SIDT2 AKAP11 CNOT4 RBFOX2	8.62e-05	191	124	7	4168_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A	CAST RFX7 WNK1 TFAP2A DICER1 CCDC88A HOXC8	9.20e-05	193	124	7	4280_DN
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; PC3; HT_HG-U133A	BAG4 AMBRA1 RFX7 LPIN1 SEC24B CAPRIN1 CNOT4	9.20e-05	193	124	7	4596_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A	PDE4A CEACAM5 AMBRA1 DICER1 ZFYVE9 MTF1 PCNX1	9.20e-05	193	124	7	1363_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	VEZT CUL7 TTBK2 SIDT2 HOXC8 PCNX1 PADI3	9.51e-05	194	124	7	6833_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	ZHX3 CUL7 WNK1 SIDT2 ZFYVE9 ZNF516 SIX2	9.51e-05	194	124	7	6811_DN
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; PC3; HT_HG-U133A	PDE4C PCDHGA1 AOAH MAP7 TGM1 SIDT2 CNOT4	9.51e-05	194	124	7	4624_UP
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A	CEACAM5 MUC16 CUL7 WNK1 CREBBP CNTNAP2 KMT2A	9.51e-05	194	124	7	4223_UP
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	NEDD4L HJURP DICER1 SIDT2 CCDC88A ASPM KDM6A	9.82e-05	195	124	7	3559_DN
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	AMBRA1 CUL7 MAP7 WNK1 ZFYVE9 CNTNAP2 PCNX1	9.82e-05	195	124	7	6561_UP
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A	POMT2 ZHX3 PDE4C WNK1 HOXC8 PCNX1 KDM6A	9.82e-05	195	124	7	4106_DN
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	LPIN1 CCDC88A PCNX1 KDM6A CNOT4 RBFOX2 KLC1	1.01e-04	196	124	7	2511_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	POMT2 CUL7 MAP7 WNK1 TFAP2A ZFYVE9 CNTNAP2	1.01e-04	196	124	7	6559_UP
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CEACAM5 NEDD4L AMBRA1 CUL7 WNK1 TTBK2 BICRAL	1.01e-04	196	124	7	3256_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A	ZHX3 PDE4A VEZT TTBK2 SIDT2 ZFYVE9 CNTNAP2	1.01e-04	196	124	7	6469_DN
Drug	Butacaine [149-16-6]; Down 200; 13uM; HL60; HT_HG-U133A	WNK1 F5 TFAP2A SIDT2 HOXC8 KDM6A RBFOX2	1.05e-04	197	124	7	2728_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A	MATR3 CUL7 MAP7 ZNF236 CCDC88A ZFYVE9 CNOT4	1.05e-04	197	124	7	1826_UP
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A	POMT2 ZHX3 ELOVL5 TTBK2 HOXC8 NKX2-1 SIX2	1.05e-04	197	124	7	7354_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	ILRUN RFX7 ZNF236 WNK1 CCDC88A HOXC8 KMT2A	1.05e-04	197	124	7	3748_DN
Drug	Diclofenac sodium [15307-79-6]; Up 200; 12.6uM; MCF7; HT_HG-U133A	ATXN7L1 MC3R ELOVL5 TTBK2 HOXC8 LATS1 PCNX1	1.08e-04	198	124	7	2756_UP
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	ZHX3 AOAH AMBRA1 F5 CREBBP CNTNAP2 KMT2A	1.08e-04	198	124	7	7282_UP
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A	SIN3B BAG4 CAST MAP7 F5 ADCY9 ZFYVE9	1.08e-04	198	124	7	2401_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	PDE4C ATXN7L1 ZNF236 CCDC88A ZFYVE9 CNTNAP2 PCNX1	1.08e-04	198	124	7	5595_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A	SIN3B CDK19 MAP7 F5 NUP160 SIX2 CUX1	1.08e-04	198	124	7	1163_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A	ILRUN CAST DICER1 TTBK2 PCNX1 KDM6A NUP160	1.08e-04	198	124	7	2362_DN
Drug	Scopoletin [92-61-5]; Down 200; 20.8uM; HL60; HT_HG-U133A	ILRUN PDE4A UBR4 CDK19 ELOVL5 ADCY9 ZFYVE9	1.08e-04	198	124	7	3131_DN
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	POMT2 CUL7 WNK1 HOXC8 ZNF516 PCNX1 KDM6A	1.08e-04	198	124	7	6841_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	CEACAM5 VEZT ATXN7L1 ADCY9 PCNX1 SIX2 CNOT4	1.11e-04	199	124	7	4313_DN
Disease	Leukemia, Myelocytic, Acute	FANCM CREBBP STAT3 KMT2A ASXL2 SLX4 CUX1	8.02e-06	173	122	7	C0023467
Disease	Kabuki syndrome 1	KMT2D KDM6A	1.70e-05	2	122	2	cv:CN030661
Disease	articulation disorder (is_implicated_in)	FOXP2 CNTNAP2	1.70e-05	2	122	2	DOID:4186 (is_implicated_in)
Disease	Kabuki syndrome (is_implicated_in)	KMT2D KDM6A	1.70e-05	2	122	2	DOID:0060473 (is_implicated_in)
Disease	KABUKI SYNDROME 1	KMT2D KDM6A	1.70e-05	2	122	2	147920
Disease	Carcinoma, Transitional Cell	CREBBP KMT2A CHD6 KDM6A	2.50e-05	41	122	4	C0007138
Disease	Bladder Neoplasm	CREBBP KMT2D KMT2A CHD6 ASXL2 KDM6A	2.64e-05	140	122	6	C0005695
Disease	Malignant neoplasm of urinary bladder	CREBBP KMT2D KMT2A CHD6 ASXL2 KDM6A	2.74e-05	141	122	6	C0005684
Disease	Kabuki syndrome (implicated_via_orthology)	KMT2D KDM6A	5.07e-05	3	122	2	DOID:0060473 (implicated_via_orthology)
Disease	primary angle-closure glaucoma (is_implicated_in)	ACVR1 COL18A1	5.07e-05	3	122	2	DOID:1405 (is_implicated_in)
Disease	Adenoid Cystic Carcinoma	FOXP2 CREBBP ASPM KDM6A RBFOX2	6.12e-05	100	122	5	C0010606
Disease	blood cobalt measurement	TSHZ2 AOAH MUC16 F5 SIX2	6.42e-05	101	122	5	EFO_0007577
Disease	Small cell carcinoma of lung	CREBBP TTBK2 CNTNAP2 KMT2A	7.50e-05	54	122	4	C0149925
Disease	Kabuki make-up syndrome	KMT2D KDM6A	1.01e-04	4	122	2	C0796004
Disease	Acute monocytic leukemia	FANCM KMT2A SLX4	1.67e-04	26	122	3	C0023465
Disease	hair colour measurement	ATXN7L1 ZFPM1 REV3L ANKRD27 KMT2D RBM27 PCNX1 ASXL2 SIPA1L2 PADI3	2.45e-04	615	122	10	EFO_0007822
Disease	stomach cancer (is_marker_for)	DICER1 STAT3 KMT2D ASPM CUX1	3.17e-04	142	122	5	DOID:10534 (is_marker_for)
Disease	hemoglobin A1 measurement	ZHX3 TSHZ3 ANK1 CAST ELOVL5 ZNF236 ANKRD27 MTF1 RBFOX2	3.21e-04	520	122	9	EFO_0007629
Disease	Syndactyly	NEDD4L TFAP2A	4.67e-04	8	122	2	C0039075
Disease	bilirubin measurement	ZHX3 ANK1 HJURP DDX42 REV3L MTF1 ASXL2 ADGRL2	5.18e-04	442	122	8	EFO_0004570
Disease	Congenital small ears	TFAP2A KMT2D KDM6A	6.55e-04	41	122	3	C0152423
Disease	thyroid gland papillary carcinoma (is_implicated_in)	KMT2D NKX2-1	7.47e-04	10	122	2	DOID:3969 (is_implicated_in)
Disease	renal Wilms' tumor (is_implicated_in)	TEK SIX2	7.47e-04	10	122	2	DOID:5176 (is_implicated_in)
Disease	Autistic Disorder	PDE4A FOXP2 CUL7 KCND2 MTF1 CNTNAP2	7.77e-04	261	122	6	C0004352
Disease	sleep duration	ANK1 FOXP2 KCTD8 TBCK KMT2A ZCCHC7 NUP160	7.91e-04	362	122	7	EFO_0005271
Disease	immunoglobulin isotype switching measurement	UBR4 STAT3 RCOR1	8.07e-04	44	122	3	EFO_0010128
Disease	Semantic-Pragmatic Disorder	FOXP2 CNTNAP2	9.10e-04	11	122	2	C0454655
Disease	Auditory Processing Disorder, Central	FOXP2 CNTNAP2	9.10e-04	11	122	2	C0751257
Disease	visual epilepsy (is_implicated_in)	CNTNAP2 ASPM	9.10e-04	11	122	2	DOID:11832 (is_implicated_in)
Disease	Language Delay	FOXP2 CNTNAP2	9.10e-04	11	122	2	C0023012
Disease	Language Development Disorders	FOXP2 CNTNAP2	9.10e-04	11	122	2	C0023014
Disease	Speech Delay	FOXP2 CNTNAP2	9.10e-04	11	122	2	C0241210
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP KMT2A	1.09e-03	12	122	2	DOID:9119 (implicated_via_orthology)
Disease	obsolete_red blood cell distribution width	ILRUN ANK1 AOAH ELOVL5 ZFPM1 WNK1 ANKRD27 ADCY9 RCOR1 RBM27 ZNF516 ASXL2 RP1 RBFOX2	1.37e-03	1347	122	14	EFO_0005192
Disease	serum gamma-glutamyl transferase measurement	ILRUN PDE4C NEDD4L ZFPM1 RCOR1 KMT2A RP1 SIPA1L2 ADGRL2 CNOT4 KLC1	1.47e-03	914	122	11	EFO_0004532
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	CNTNAP2 RNF111	1.49e-03	14	122	2	OBA_2045142
Disease	QRS duration	ILRUN UBR4 ZFPM1 KMT2A HEATR5B NUP160	1.53e-03	298	122	6	EFO_0005055
Disease	hippocampal atrophy	F5 COL18A1 CHD6	1.63e-03	56	122	3	EFO_0005039
Disease	glycerol-3-phosphate measurement	NEDD4L CNTNAP2	1.72e-03	15	122	2	EFO_0010488
Disease	Lymphoma, Follicular, Grade 2	CREBBP KMT2D	1.72e-03	15	122	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	CREBBP KMT2D	1.72e-03	15	122	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	CREBBP KMT2D	1.72e-03	15	122	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	CREBBP KMT2D	1.72e-03	15	122	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	CREBBP KMT2D	1.72e-03	15	122	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	CREBBP KMT2D	1.72e-03	15	122	2	C0079758
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TSHZ3 FOXP2 TSHZ2 REV3L KCND2 TNRC6A BICRAL SIPA1L2 ADGRL2 CUX1	1.85e-03	801	122	10	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	T-Cell Lymphoma	STAT3 KMT2D	1.96e-03	16	122	2	C0079772
Disease	autism spectrum disorder (is_implicated_in)	FOXP2 CNTNAP2	1.96e-03	16	122	2	DOID:0060041 (is_implicated_in)
Disease	major depressive disorder (is_implicated_in)	FOXP2 CNTNAP2	2.21e-03	17	122	2	DOID:1470 (is_implicated_in)
Disease	Crohn's disease	FOXP2 TSHZ2 FAM171B STAT3 CNTNAP2 AKAP11 CHD6	2.44e-03	441	122	7	EFO_0000384
Disease	Bone marrow hypocellularity	FANCM SLX4	2.48e-03	18	122	2	C1855710
Disease	Hemangiosarcoma	TEK COL18A1	2.48e-03	18	122	2	C0018923
Disease	Colorectal Carcinoma	SLC22A15 GPR87 WNK1 F5 WAC LPIN1 ADAMTS15 KDM6A CUX1	2.61e-03	702	122	9	C0009402
Disease	MYELODYSPLASTIC SYNDROME	FANCM SLX4 CUX1	2.72e-03	67	122	3	C3463824
Disease	congenital heart disease (implicated_via_orthology)	KMT2D KMT2A CHD6	2.96e-03	69	122	3	DOID:1682 (implicated_via_orthology)
Disease	diet measurement, body mass index	CMYA5 CNTNAP2	3.07e-03	20	122	2	EFO_0004340, EFO_0008111
Disease	Lymphoma, Follicular	CREBBP KMT2D	3.07e-03	20	122	2	C0024301
Disease	schizophrenia, intelligence, self reported educational attainment	FOXP2 AMBRA1 KMT2A PCNX1 CNOT4 KLC1	3.22e-03	346	122	6	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	Anophthalmia-microphthalmia syndrome	TFAP2A NHS	3.38e-03	21	122	2	cv:C5680330
Disease	gastric ulcer (biomarker_via_orthology)	TEK COL18A1	3.38e-03	21	122	2	DOID:10808 (biomarker_via_orthology)
Disease	pentachlorophenol measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022071
Disease	parathion measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022070
Disease	potassium chromate measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022072
Disease	mercuric chloride measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022068
Disease	heptachlor epoxide measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022067
Disease	methoxychlor measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022052
Disease	azinphos methyl measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022055
Disease	aldrin measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022054
Disease	dicofol measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022060
Disease	disulfoton measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022062
Disease	dieldrin measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022061
Disease	endrin measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022064
Disease	endosulfan measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022063
Disease	heptachlor measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022066
Disease	ethion measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022065
Disease	chlorpyrifos measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022057
Disease	cadmium chloride measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022056
Disease	diazinon measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022059
Disease	dibutyl phthalate measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0022058
Disease	environmental exposure measurement	TSHZ2 MUC16 F5	3.47e-03	73	122	3	EFO_0008360
Disease	DDT metabolite measurement	TSHZ2 MUC16 F5	3.61e-03	74	122	3	EFO_0007886
Disease	autism spectrum disorder (implicated_via_orthology)	TSHZ3 CREBBP CNTNAP2 CHD6	3.71e-03	152	122	4	DOID:0060041 (implicated_via_orthology)
Disease	atopic eczema	KCTD8 REL STAT3 KCND2 RNF111	4.03e-03	252	122	5	EFO_0000274

Protein segments in the cluster

Peptide	Gene	Start	Entry
ATSDHPNNQDQSSSL	BAG4	351	O95429
AGLQHSQDSSLNQVP	CDK19	421	Q9BWU1
RNPGEQASNTNGTHQ	CUX1	436	P39880
ENNANPNLATTAGHT	ANK1	491	P16157
SGENLNLSCHAASNP	CEACAM5	251	P06731
RSFNSHINASNNSEP	MASTL	656	Q96GX5
HSQSTNQLDVGNNPR	ACVR1	361	Q04771
NNPNSHTDNNAKSSD	TFAP2A	416	P05549
FNQTHPGLLNSNSGH	CREBBP	181	Q92793
PGLLNSNSGHSLINQ	CREBBP	186	Q92793
SNSGHSLINQASQGQ	CREBBP	191	Q92793
NSPGHSLNNARDTSA	ADGRL2	1206	O95490
PHNSSVGSLSENEQN	AKAP11	1141	Q9UKA4
SNNAIASLAFHPTAQ	AMBRA1	136	Q9C0C7
NAAHQGANRTSSLEN	DICER1	1131	Q9UPY3
GNLTVDHIQNNSDSG	CBLL2	236	Q8N7E2
LHSSGINVNAAPFQS	CAPRIN1	501	Q14444
QAATESVPNSGNIHN	FAM193A	956	P78312
SVPNSGNIHNGSLEQ	FAM193A	961	P78312
LSPDSFVNNSHGANN	ASPM	316	Q8IZT6
NSLSVHNSNNGVSPL	ATXN7L1	696	Q9ULK2
SQAQPHSVSGAQLQQ	ASXL2	761	Q76L83
NASAPAAQRNSQGAH	ADAMTS15	141	Q8TE58
PQQTSDLHVQGNSSG	HJURP	536	Q8NCD3
APGAASLQGHAQQQA	NKX2-1	276	P43699
AAAASAAAAPNNGQN	RCOR1	56	Q9UKL0
AAAAPNNGQNKSLAA	RCOR1	61	Q9UKL0
NNHSSSNSFGRNLPP	RBM27	261	Q9P2N5
GGNQSDASHLLNQSG	RBM27	756	Q9P2N5
QAHGEQSSNSPSTQN	RBFOX2	76	O43251
ANDDQSRPSLSNGHT	AOAH	26	P28039
LRQNNLPAQSGSHAA	ANKRD27	981	Q96NW4
HGPQNTAASTLNTDA	MUC16	2111	Q8WXI7
DNPSSAQQATAHQPN	KCTD8	371	Q6ZWB6
LSNNSLSNLAPGAFH	LRTM1	81	Q9HBL6
PLSSQHRGDADQASN	MATR3	96	P43243
SSRPASAISGQNNNH	MAP7	36	Q14244
NLPNNSHGITDFSSN	MUC15	76	Q8N387
NNPLGNRASHSANSQ	LATS1	466	O95835
AVNGHTNSFSPLENN	ELOVL5	276	Q9NYP7
QDHCLNSVPSGSSAQ	FANCM	1701	Q8IYD8
PSNSVTQGAALNHLS	KDM6A	686	O15550
HPLLALSTNNCNNSA	KIAA1614	871	Q5VZ46
SLNSVPTNSAQQGHN	DDX42	736	Q86XP3
AVNNQSRPQSHSSGE	CCDC88A	1611	Q3V6T2
TSCTGNNATTANNPH	PCNX1	2056	Q96RV3
ANNPHSNVTQGSIGN	PCNX1	2066	Q96RV3
DHPGVSNQFLINTNS	PDE4A	476	P27815
DHPGVSNQFLINTNS	PDE4C	431	Q08493
SHVANSVGPGLANNS	COL18A1	306	P39060
QLNDSAAEPGAQNTS	CUL7	266	Q14999
HNPNEAEQCGTNSSQ	FAM214A	251	Q32MH5
NGSLDHIDSNGNSSP	FOXP2	646	O15409
PDSLGSFQQQHTALQ	ZFPM1	396	Q8IX07
SFQQQHTALQGPLAS	ZFPM1	401	Q8IX07
PNANVSGSHQGSIQE	KCND2	541	Q9NZV8
HASDNGARSANQSPQ	LPIN1	426	Q14693
NSPSNDLNDSHVQIS	PADI3	81	Q9ULW8
DQGNLHTSVSSAQGQ	CRNN	456	Q9UBG3
PNNELHGQESHNSGN	GPR87	11	Q9BY21
ANIENSGLPHNSSAN	TMEM123	36	Q8N131
QNSVNLSPSSHANNL	ILRUN	266	Q9H6K1
QLQPNSASGSGALEH	HEATR5B	741	Q9P2D3
GSSQQFAQAQLHPSS	BICRAL	131	Q6AI39
QAQTLQNHSGLSAPV	CHD6	1166	Q8TD26
LFNSSANVHAAANGQ	C14orf132	31	Q9NPU4
GHNILSHPETQSQNS	CMYA5	3121	Q8N3K9
NTAQAQDGSHPQEHL	ADCY9	1121	O60503
LPKQASDTGSNDAHN	CAST	66	P20810
NGSEHLQAPFFSNQS	MC3R	16	P41968
SSANTNSSEGQGHLN	HOXC8	116	P31273
NSSEGQGHLNQNSSP	HOXC8	121	P31273
AAHQAAQDNENSAPI	KLF17	21	Q5JT82
HGNNQDLTRNSSTPG	KMT2A	3016	Q03164
NNSSHSVLQPSFQGC	CNTNAP2	506	Q9UHC6
NGHILPNSENAHGQS	FMR1NB	101	Q8N0W7
LPNQSHGNQSAGEDQ	SLC22A15	56	Q8IZD6
RNHTGSLAVANNNPT	SEC24B	276	O95487
ANQLLNGNHQSGSSS	SBSN	541	Q6UWP8
VEQAPSGQHSQAQLS	POLRMT	206	O00411
HINNNLSSSLGDAQD	FAM171B	496	Q6P995
DPGQGIQQQHSSAAA	KLC1	186	Q07866
QLSSNPHFSLDVQQG	PCDHGA1	171	Q9Y5H4
SHNNGLPSTISNNSI	RP1	561	P56715
NCSNNSFSGNDPHTN	RP1	946	P56715
PSPALSFAHNGNNNN	MEX3B	321	Q6ZN04
PGNNSNFTSPLESNH	PYGO1	206	Q9Y3Y4
AHPLGNLSAFNNILS	SIDT2	491	Q8NBJ9
QLSSAHSGTPQNNGN	TMC3	756	Q7Z5M5
SSAFQARLSGNNLHN	POMT2	316	Q9UKY4
SLPDHNQNSSNDTGQ	F5	1096	P12259
SPQSTDDAHQGSQGA	NHS	1556	Q6T4R5
NALPQHNGSEDTNHS	MTF1	321	Q14872
DQNAVNPNTGAALHR	SIPA1L2	176	Q9P2F8
QSPLTSQENSHNHGD	SIN3B	121	O75182
SSPELNCNNEINGHT	SGO2	301	Q562F6
PGPNHTSNSSNASNA	WAC	526	Q9BTA9
LGENSANSHNIALSQ	NUP160	1396	Q12769
YPSGAHDTSNATLNN	SLC12A4	236	Q9UP95
NNPHLSDVQFQTDSG	SLX4	686	Q8IY92
LNHTANPTSNSNFLD	CNOT4	511	O95628
GNLFTNLDSLNAHNA	ZNF516	341	Q92618
SSTLAGHLPANNNNS	ZXDB	641	P98169
ALNVALGNPSSTAQH	REV3L	86	O60673
NSDNPLNNENSRTHS	REV3L	531	O60673
DLFVSASENHQNNPA	RNF111	276	Q6ZNA4
LQSGSHLANNSDPES	SEC16A	286	O15027
NIHAPIANESASSQA	TRO	181	Q12816
TAAQQGGQANHPTAA	STAT3	121	P40763
LGQPDQALFHSLNSS	RFX8	466	Q6ZV50
RPQDHSAQQTNTAGS	UBQLN1	111	Q9UMX0
NSHGQANGLLNAPSL	TTBK2	406	Q6IQ55
ALQHALQASGQPSLQ	UBL7	321	Q96S82
SSHIGANQPLNSSAL	RFX7	626	Q2KHR2
SNSTNPNSHGFVQDS	REL	581	Q04864
NNIGSSNPAFSHELV	TEK	716	Q02763
HLFQQNQTSSPDSSN	USP9Y	26	O00507
DDQSNLPHSNSNNEL	TBCK	406	Q8TEA7
LPHSNSNNELSAAAT	TBCK	411	Q8TEA7
YQNSPGSHLSNQDAE	TSHZ2	66	Q9NRE2
LNLHQPSSEKNNGSS	TSHZ3	136	Q63HK5
ENSNSNSHNPLNGSG	SIX2	191	Q9NPC8
HFPNGNLSQLAAAVA	UNC5A	811	Q6ZN44
NIHGNALFQSSNLGD	ZNF677	546	Q86XU0
VSSTLAGHLPANNNN	ZXDA	636	P98168
AGHLPANNNNSVGQA	ZXDA	641	P98168
QAQENAHGLSSSLQS	ZCCHC7	111	Q8N3Z6
SFHQQSLLQAPSSDG	ZNF236	916	Q9UL36
SGQNLNLRVHTSPNA	TGM1	201	P22735
NLSGQSAASVLHPQQ	WNK1	2151	Q9H4A3
SAGQSQQQENGHLPT	VEZT	121	Q9HBM0
VTNALSQSNGQGPSH	UBR4	1606	Q5T4S7
QASASSAKNPHAANG	ZHX3	241	Q9H4I2
PSNQHSNDSANGNGK	TNRC6A	621	Q8NDV7
SDHLQNDFPANSGNN	ZFYVE9	596	O95405
PSSDLQNHVAAGSGQ	KMT2D	3466	O14686
PAQNHSSLSNVSQAV	LRRC8C	61	Q8TDW0
SGSATNSNNHLIEPQ	NEDD4L	426	Q96PU5